Table 6-1Emergency HotlinesNeedAgencyPhone Number and Web AddressTo obtain information regarding the treatment of a known or suspected poisoning or toxicosis caseAmerican Society for the Prevention of Cruelty to Animals (ASPCA) Animal Poison Control Center. A \$65 fee for service may apply.888-426-4435\
[www.aspca.org](http://www.aspca.org){#ir0010}\
Search: *pet care; animal poison control*To obtain information regarding the treatment of a known or suspected poisoning or toxicosis casePet Poison Helpline\
Available 24 hours; a \$35 fee is charged per case.800-213-6680To report known or suspected adverse drug (not vaccine) reactionsFood and Drug Administration (FDA), Center for Veterinary Medicine (CVM)888-332-8387 (voice messages accepted)[www.fda.gov](http://www.fda.gov){#ir0015}\
Search: *animal and veterinary*To report shortages of medically necessary veterinary drugsFood and Drug Administration (FDA), Center for Veterinary Medicine (CVM)240-276-9239To report known or suspected adverse vaccine reactionsU.S. Dept of Agriculture (USDA), Center for Veterinary Biologics\
It is recommended to contact the vaccine manufacturer directly before contacting the USDA.\
*Note:* This is for reporting purposes only.800-752-6255\
[www.aphis.usda.gov](http://www.aphis.usda.gov){#ir0020}\
Search: *vaccine adverse event*For inquiries regarding transfusion medicineAnimal Blood Bank hotline (no charge to caller)800-243-5759 (24-hour)\
[www.animalbloodbank .com](http://www.animalbloodbank.com){#ir0025}For inquiries regarding transfusion medicine and purchase of blood and blood\
componentsEastern Veterinary Blood Bank800-949-3822 (24-hour)\
[www.evbb.com](http://www.evbb.com){#ir0030}For inquiries regarding transfusion medicine---a full-service, nonprofit blood bank and educational network for animal treatmentHEMOPET714-891-2022 (24-hour)\
[www.hemopet.org](http://www.hemopet.org){#ir0035}Access to a commercial blood bank and purchase of blood and blood componentsVeterinarians' Blood Bank812-358-8500\
[www.vetbloodbank.com](http://www.vetbloodbank.com){#ir0040}For inquiries regarding pesticides, pesticide products, poisonings, and toxicitiesNational Pesticide Information Center800-858-7378For inquiries regarding pet shipping regulations and regulations for shipping pets on airlinesU.S. Dept of Agriculture (USDA)\
(voice response service)800-545-8732\
[www.aphis.usda.gov](http://www.aphis.usda.gov){#ir0045}\
Search: *pet travel*To contact the Office of\
Diversion Control of the DEADrug Enforcement Administration (DEA)800-882-9539\
[www.dea.gov](http://www.dea.gov){#ir0050}

Table 6-2Dog Breeds Recognized by The American Kennel Club (AKC)The American Kennel Club (AKC) currently recognizes 150 dog breeds, each of which is assigned to one of seven breed groups. The AKC maintains an excellent website that offers considerable information on individual breeds ([www.akc.org/breeds/index.cfm](http://www.akc.org/breeds/index.cfm){#ir0055}).S[porting group]{.smallcaps}American Water SpanielBoykin SpanielBrittanyChesapeake Bay RetrieverClumber SpanielCocker SpanielCurly-Coated RetrieverEnglish Cocker SpanielEnglish SetterEnglish Springer SpanielField SpanielFlat-Coated RetrieverGerman Shorthaired PointerGerman Wirehaired PointerGolden RetrieverGordon SetterIrish Red and White SetterIrish SetterIrish Water SpanielLabrador RetrieverNova Scotia Duck Tolling RetrieverPointerSpinone ItalianoSussex SpanielVizslaWeimaranerWelsh Springer SpanielWirehaired Pointing GriffonH[ound group]{.smallcaps}Afghan HoundAmerican FoxhoundBasenjiBasset HoundBeagleBlack and Tan CoonhoundBloodhoundBluetick CoonhoundBorzoiDachshundEnglish FoxhoundGreyhoundHarrierIbizan HoundIrish WolfhoundNorwegian ElkhoundOtterhoundPetit Basset Griffon VendéenPharaoh HoundPlottRedbone CoonhoundRhodesian RidgebackSalukiScottish DeerhoundWhippetW[orking group]{.smallcaps}AkitaAlaskan MalamuteAnatolian Shepherd DogBernese Mountain DogBlack Russian TerrierBoxerBullmastiffCane CorsoDoberman PinscherDogue de BordeauxGerman PinscherGiant SchnauzerGreat DaneGreat PyreneesGreater Swiss Mountain DogKomondorKuvaszLeonbergerMastiffNeapolitan MastiffNewfoundlandPortuguese Water DogRottweilerSaint BernardSamoyedSiberian HuskyStandard SchnauzerTibetan MastiffT[errier group]{.smallcaps}Airedale TerrierAmerican Staffordshire TerrierAustralian TerrierBedlington TerrierBorder TerrierBull TerrierCairn TerrierDandie Dinmont TerrierGlen of Imaal TerrierIrish TerrierKerry Blue TerrierLakeland TerrierManchester TerrierMiniature Bull TerrierMiniature SchnauzerNorfolk TerrierNorwich TerrierParson Russell TerrierScottish TerrierSealyham TerrierSkye TerrierSmooth Fox TerrierSoft Coated Wheaten TerrierStaffordshire Bull TerrierWelsh TerrierWest Highland White TerrierWire Fox TerrierT[oy group]{.smallcaps}AffenpinscherBrussels GriffonCavalier King Charles SpanielChihuahuaChinese CrestedEnglish Toy SpanielHavaneseItalian GreyhoundJapanese ChinMalteseManchester Terrier (Toy)Miniature PinscherPapillonPekingesePomeranianPoodlePugShih TzuSilky TerrierToy Fox TerrierYorkshire TerrierN[on-sporting group]{.smallcaps}American Eskimo DogBichon FriseBoston TerrierBulldogChinese Shar-PeiChow ChowDalmatianFinnish SpitzFrench BulldogKeeshondLhasa ApsoLöwchenNorwegian LundehundPoodleSchipperkeShiba InuTibetan SpanielTibetan TerrierXoloitzcuintliH[erding group]{.smallcaps}Australian Cattle DogAustralian ShepherdBearded CollieBeauceronBelgian MalinoisBelgian SheepdogBelgian TervurenBorder CollieBouvier des FlandresBriardCanaan DogCardigan Welsh CorgiCollieEntlebucher Mountain DogGerman Shepherd DogIcelandic SheepdogNorwegian BuhundOld English SheepdogPembroke Welsh CorgiPolish LowlandPuliPyrenean ShepherdShetland SheepdogSwedish VallhundM[iscellaneous class]{.smallcaps}American English CoonhoundBergamascoBoerboelCesky TerrierChinookDogo ArgentinoFinnish LapphundPeruvian IncaRat TerrierRussell TerrierSloughiTreeing Walker CoonhoundWirehaired Vizsla

Table 6-3Cat Breeds Recognized by the Cat Fanciers' Association (CFA)The Cat Fanciers' Association (CFA) presently recognizes 41 pedigreed breeds for showing in the Championship Class. For additional information on individual breeds, see the CFA website, [www.cfa.org](http://www.cfa.org){#ir0060} (Search: Breeds)C[hampionship class]{.smallcaps}AbyssinianAmerican BobtailAmerican CurlAmerican ShorthairAmerican WirehairBalinese (including Javanese)BirmanBombayBritish ShorthairBurmeseChartreuxChinese Li HuaColorpoint ShorthairCornish RexDevon RexEgyptian MauEuropean BurmeseExoticHavana BrownJapanese BobtailKoratLaPermMaine CoonManxNorwegian Forest CatOcicatOrientalPersianRagaMuffinRagdollRussian BlueScottish FoldSelkirk RexSiameseSiberianSingapuraSomaliSphynxTonkineseTurkish AngoraTurkish Van

Table 6-4Useful Information for Rodents and RabbitsHamsterRabbitMouseRatGerbilGuinea PigWeight at birth2 g100 g1.5 g5.5 g3 g100 gPuberty(F) 28-31 days\
(M) 45 days\
(best to breed at 70 days)4-9 mo35 days50-60 days(F) 3-5 mo\
(M) 10-12 wk(F) 20-30 days\
(M) 70 daysDuration of estrous cycle[\*](#tf0010){ref-type="table-fn"}4 daysOvulation not spontaneous; stimulated by copulation; doe ovulates 10-13 hr after copulation4 days4 days4 days16 daysGestation (days)1628-3619-2121-232462-72Separation of adults during parturition and weaningYesYesNoNoNo (mates for life)NoNumber per litter4-107108-101-121-4Eyes open15 days10 days11-14 days14-17 days16-20 daysBefore birthWean at25 days42-56 days21 days21 days21 days14-21 days or 160 gPostpartum estrusWithin 24 hr14 daysWithin 24-48 hrWithin 24-48 hrWithin 24-72 hrWithin 24 hrBreeding life11-18 mo1-3 yr (maximum 6 yr)12-18 mo14 mo15-20 mo3-4 yrAdult weight(F) 120 g\
(M) 108 g(F) 4.0 kg\
(M) 4.3 kg(F) 30 g\
(M) 39 g(F) 300 g\
(M) 500 g(F) 75 g\
(M) 85 g(F) 850 g\
(M) 1000 gLife span (yr)2-35-73.0-3.5344-5Body temperature97°-101° F (36.1°-38.3° C)101°-103.2° F (38.3°-39.5° C)96.4°-100° F (35.8°-37.7° C)99.5°-100.6° F (37.5°-38.1° C)100.8° F (32.8° C)100.4°-102.5° F (38-39.2° C)Daily adult water consumption8-12 mL/day80 mL/kg body weight3-3.5 mL/day20-30 mL/day4 mL/day10 mL/100 g body weightDaily adult food consumption (varies with age and condition)7-12 g/day100-150 g/day2.5-4.0 g/day20-40 g/day10-15 g/day30-35 g/dayDietCommercial rat, mouse, or hamster chow supplemented with kale,[†](#tf0015){ref-type="table-fn"} cabbage,[†](#tf0015){ref-type="table-fn"} apples, milkCommercial rabbit pellets, greens in moderationCommercial mouse chowCommercial rat or mouse chowCommercial mouse or rat chow with lowest fat content possible; sunflower seedsCommercial guinea pig chow, good-quality hay, kale, cabbage, fruits (cannot rely on vitamin C levels of commercial ration)Room temperature65°-75° F (18.3°-24° C)62°-68° F (17°-20° C)70°-80° F (21°-27° C)76°-18° F (24.5°-25.5° C)65°-80° F (18.3°-26.6° C)65°-75° F (18.3°-24° C)Humidity (%)50505050\<5050[^1][^2]From Schuchman SM: Individual care and treatment of rabbits, mice, rats, guinea pigs, hamsters, and gerbils. In Kirk RW, editor: *Current veterinary therapy X,* Philadelphia, 1989, WB Saunders.

Table 6-5Determination of the Sex of Mature and Immature Rodents and RabbitsMaleFemaleM[ature hamsters, mice, rats, guinea pigs, and gerbils]{.smallcaps}Anogenital distance longer in the male.\
Manipulate "genital papilla" (prepuce) to the protrude penis.\
Palpate for testicles either in a scrotal sac (if present) or subcutaneous in inguinal region.\
Males have only two external openings in the inguinal area:a.Anusb.Urethral orifice at tip of penis In very fat males there may be a depression between the penis and anus. This depression can be obliterated by manipulating the skin in this area.Anogenital distance shorter in the female.\
Look for the three external openings in inguinal area:a.Anus (most caudal opening)b.Vaginal orifice (middle opening)---look carefullyc.Urethral orifice at tip of urethral papilla (most anterior opening). In these animals the urethral papilla is located outside the vagina (unlike in dogs and cats). In very fat or young females, the vaginal orifice may be either hidden by folds of skin (the former) or sealed (latter). Gentle manipulation of the skin in this area will divulge the orifice.M[ature rabbits]{.smallcaps}Protrude penis by manipulating skin of prepuce.\
Palpate for testicles.\
Anogenital distance is longer in males.There is a common orifice for both the vagina and urethra (as in dogs and cats).\
No structure like a "penis" can be protruded from the urogenital orifice.\
Anogenital distance is shorter in females.From Schuchman SM: Individual care and treatment of rabbits, mice, rats, guinea pigs, hamsters, and gerbils. In Kirk RW, editor: *Current veterinary therapy X,* Philadelphia, 1989, WB Saunders.

Table 6-6Blood Values and Serum Chemical Constituents for Rodents and Rabbits[\*](#tf0020){ref-type="table-fn"}Laboratory TestRatsMiceHamstersGuinea PigsRabbitsMongolian GerbilsAST (Sigma-Frankel units)25-4232-4122-3610-2514-27---Alkaline phosphatase (Bodansky units)4.1-8.62.4-4.02.0-3.51.5-8.12.1-3.2---BUN (mg/dL)10-208-3010-408-205-3018-24Sodium (mEq/L)144114-154106-185120-155100-145144-158Potassium (mEq/L)5.93.0-9.62.3-9.86.5-8.23.0-7.03.8-5.2Bilirubin, total (mg/dL)0.420.18-0.540.3-0.40.24-0.300.15-0.20---Blood glucose (mg/dL)50-115108-19232.6-118.460-12550-14069-119RBCs (106 cells/mm^3^)7.2-9.69.3-10.54.0-9.34.5-7.03.2-7.58.3-9.3Hemoglobin (g/dL)14.812-14.99.7-16.811-1510-1510-16Hematocrit (%)40-5035-5040-5235-5035-4535-45WBCs (103 cells/mm^3^)8-148-147-155-128-109-14Segmented (%)302616-284230-5010-20Nonsegmented (%)008000Lymphocytes (%)65-7755-8064-7845-8130-5070-89Eosinophils (%)131511Monocytes (%)452890Basophils (%)000200[^3][^4]Modified from Schuchman SM: Individual care and treatment of rabbits, mice, rats, guinea pigs, hamsters, and gerbils. In Kirk RW, editor: *Current veterinary therapy X,* Philadelphia, 1989, WB Saunders.

Table 6-7Ferrets---Physiologic, Anatomic, and Reproductive DataDataRange or ValueP[hysiologic data]{.smallcaps}Life span5-9 yr (average 5-7)Commercial breeding life2-5 yrBody temperature101°-104° F (38°-40° C)Respiratory rate32-36 breaths/minHeart rate220-250 beats/min (average 240)Water consumption75-100 mL/dayChromosome number2n = 40A[natomic data]{.smallcaps}Dental formula2 (I3/3, C1/1, P3/4, M1/2)Vertebral formulaC-7, T-14, L-6, S-3, Cd-14--Cd-18R[eproductive data]{.smallcaps}Gestation39-46 days (average 42)Litter size2-17 kits (average 8)False pregnancy40-42 daysPlacentationZonalImplantation time12-31 daysWeaning5-6 wkOvulation30-40 hr postcoitusFrom Randolph RW: Medical and surgical care of the pet ferret. In Kirk RW, editor: *Current veterinary therapy X,* Philadelphia, 1989, WB Saunders.

Table 6-8Hematologic Values for Normal Ferrets[\*](#tf0025){ref-type="table-fn"}Laboratory TestMeanRangeHematocrit (%)52.342-61Hemoglobin (g/dL)17.015-18RBCs (10^6^ cells/mm^3^)9.176.8-12.2WBCs (10^3^ cells/mm^3^)10.14.0-19WBCsLymphocytes (%)34.512-54Neutrophils (%)58.311-84Monocytes (%)4.40-9.0Eosinophils (%)2.50-7.0Basophils (%)0.10-2.0Reticulocytes (%)4.61-14Platelets (10^3^ cells/mm^3^)499297-910Total protein (g/dL)6.05.1-7.4[^5][^6]From Ryland L, Bernard S, Gorham J: A clinical guide to the pet ferret, *Compend Contin Educ Pract Vet* 5:25, 1983, which was adapted from Thornton PC, Wright PA, Sacra PJ, Goodier TE: The ferret, *Mustela putorius furo,* as a new species in toxicology, *Lab Anim* 13:119, 1979.

Table 6-9Serum Chemistry Values for Normal Ferrets[\*](#tf0030){ref-type="table-fn"}AnalyteUnitMeanRangeGlucosemg/dL13694-207BUNmg/dL2210-45Albuminmg/dL3.22.3-3.8Alkaline phosphataseInternational units/L239-84ASTInternational units/L6528-120Total bilirubinmg/dL\<1.0Cholesterolmg/dL16564-296Creatininemg/dL0.60.4-0.9SodiummEq/L148137-162PotassiummEq/L5.94.5-7.7ChloridemEq/L116106-125Calciummg/dL9.28.0-11.8Phosphorusmg/dL5.94.0-9.1[^7][^8]From Ryland L, Bernard S, Gorham J: A clinical guide to the pet ferret, *Compend Contin Educ Pract* Vet 5:25, 1983, which was adapted from Thornton PC, Wright PA, Sacra PJ, Goodier TE: The ferret, *Mustela putorius furo,* as a new species in toxicology, *Lab Anim* 13:119, 1979.

Table 6-10Electrocardiographic Data for Normal Ferrets[\*](#tf0035){ref-type="table-fn"}ParameterMeanRangeRate rhythm224 ± 51150-340 bpmM[easurements]{.smallcaps}P wave Width0.03 ± 0.0090.015-0.04 s Height0.106 ± 0.030.05-0.20 mVPR interval Width0.05 ± 0.010.04-0.08 sQRS complexQ waveUsually noneR wave Width0.049 ± 0.0080.04-0.06 s Height1.59 ± 0.630.6-3.15 mVS wave Height0.166 ± 0.1010.1-0.25 mVST segment Width0.030 ± 0.0160.01-0.06 sQT interval Width0.13 ± 0.0270.10-0.18 sT wave Width0.06 ± 0.010.03-0.1 s Height0.24 ± 0.120.10-0.45 mVMean electrical axis (frontal plane)+65-100 degrees[^9][^10]

Table 6-11Conversion of Body Weight in Kilograms to Body Surface Area in Square Meters for DogsKilogramsSquare MetersKilogramsSquare Meters0.500.0626.000.881.000.1027.000.902.000.1528.000.923.000.2029.000.944.000.2530.000.965.000.2931.000.996.000.3332.001.017.000.3633.001.038.000.4034.001.059.000.4335.001.0710.000.4636.001.0911.000.4937.001.1112.000.5238.001.1313.000.5539.001.1514.000.5840.001.1715.000.6041.001.1916.000.6342.001.2117.000.6643.001.2318.000.6944.001.2519.000.7145.001.2620.000.7446.001.2821.000.7647.001.3022.000.7848.001.3223.000.8149.001.3424.000.8350.001.3625.000.85

Table 6-12Conversion of Body Weight in Kilograms to Body Surface Area in Square Meters for CatsKilogramsSquare Meters0.500.061.000.101.500.122.000.152.500.173.000.203.500.224.000.244.500.265.000.285.500.296.000.316.500.337.000.347.500.368.000.388.500.399.000.419.500.4210.000.44

Table 6-13French Scale Conversion TableThe standard French, or Charrière, scale (abbreviated F or Fr) is generally used in the size calibration of catheters and other tubular instruments. It is based on the metric system, with each unit being approximately 0.33 mm, with a difference of 0.33 mm in diameter between consecutive sizes. Example: 27F indicates a diameter of 9 mm; 30F, a diameter of 10 mm.A convenient conversion table from the French scale to the English and American scales that is sometimes used for certain instruments is given here.![](t06-13-9781437707984.gif)

Table 6-14International System of Units (SI) Conversion Guide[\*](#tf9500){ref-type="fn"}Conversion FactorAnalyteFluidTraditional UnitsMultiply (×)→\
 ←Divide (÷)SI UnitsACTH (adrenocorticotropin; corticotropin)Plasmapg/mL0.2202pmol/LALT (alanine aminotransferase; SGPT)Serummg/dL1units/LAlbuminSerumg/dL10g/LAldosteroneSerumng/dL27.74pmol/LAmmonia (NH[@bb0020])Plasmamcg/dL0.5872µmol/LAmmonium (NH^4+^)Plasmamcg/dL0.5543µmol/LAmylaseSerumunits/L1units/LAntibodiesSerumHighest possible dilution1Highest possible dilutionAST (aspartate aminotransferase; SGOT)Serumunits/L1units/LBile acids (total)Serummcg/mL2.547µmol/LBilirubin (total)Serummg/dL17.1µmol/LBlood gases:Arterial blood Pco~2~mm Hg0.1333kPa pHpH units1pH units Po~2~mm Hg0.1333kPaBUN (blood urea nitrogen)Serummg/dL0.357mmol/L of ureaCalciumSerummg/dL0.250mmol/LCalcium, ionized (iCa)Serum, plasmamEq/L0.500mmol/LCBC (complete blood count):Whole blood Hematocrit%0.01as a fraction of 1 Hemoglobing/dL10g/L MCH (mean corpuscular hemoglobin)pg1pg MCHC (mean corpuscular hemoglobin concentration)g/dL10\
1g/LMCV (mean corpuscular volume)µm^2^1fL Platelet count103/mm^3^1109/L Reticulocyte countNo. per 1000 red blood cells (RBCs)0.001as a fraction of 1 Reticulocyte countAs a %0.01as a fraction of 1Differential cell countNeutrophils (segmented)cells/mm^3^ (mcL)1106 cells/LNeutrophils (band)cells/mm^3^1 Lymphocytescells/mm^3^1 Monocytescells/mm^3^1 Eosinophilscells/mm^3^1 Basophilscells/mm^3^1Cholesterol (total)Serummg/dL0.02586mmol/LCK (creatine kinase)Serumunits/L1units/LCortisolSerum, plasmamcg/dL27.59nmol/LCortisol (free)Urinemcg/24 hr2.759nmol/dayCreatinineSerummg/dL88.4µmol/LElectrolytes ChlorideSerummEq/L1mmol/L BicarbonateWhole bloodmEq/L1mmol/L PotassiumSerummEq/L1mmol/L SodiumSerummEq/L1mmol/LFibrinogen (coagulation factor I)Plasmag/dL29.41µmol/Lor0.01g/Lmg/dLFibrin (fibrin degradation products)Serummcg/mL1mg/LGGT (γ-glutamyltransferase)Serumunits/L1units/LGlucoseSerummg/dL0.05551mmol/LInsulinSerumμU/mL7.175pmol/LmU/L7.175pmol/Lmcg/L172.2pmol/LLeadPlasmamcg/dL0.04826µmol/Lmg/dL48.26µmol/LLipaseSerumunits/L1units/LMagnesiumSerummg/dL0.4114mmol/LmEq/L0.500mmol/LPhosphorusSerummg/dL0.3229mmol/LPlasminogenPlasma%0.01as a fraction of 1Protein (total)Serumg/dL10g/LProtein (spinal fluid)Cerebrospinal fluid (CSF)mg/dL0.01g/LPT (prothrombin time)Plasmaseconds1secondsPTT (partial thromboplastin time)Plasmaseconds1secondsThyroid tests TSH (thyroid-stimulating hormone)SerumμU/mL1mU/L T~4~ (thyroxine)Serummcg/dL12.87nmol/L Thyroxine, free T~4~Serumng/dL12.87pmol/L T~3~ (triiodothyronine)Serumng/dL0.01536nmol/L

Table 6-15Units of Length, Volume, and Mass in the Metric SystemPrefixMultiply byFactormilli-0.001 (1/1000)× 10^−3^centi-0.01 (1/1000)× 10^−2^deci-0.1 (1/10)× 10^−1^deka-10× 10hecto-100× 10^2^kilo-1000× 10^3^ParameterUnitAbbreviationsThe standard unit of volume in the metric system is the liter.1 milliliter = 0.001 liter1 milliliter = 1 mL = 1 cc[\*](#tf0045){ref-type="table-fn"}1 centiliter = 0.01 liter1 centiliter = 1 cL1 deciliter = 0.1 liter1 deciliter = 1 dL1 liter1 liter = 1 L1 kiloliter = 1000 liters1 kiloliter = 1 kLThe standard unit of mass in the metric system is the gram.1 nanogram = 10^-9^ gram1 nanogram = 1 ng1 microgram = 10^-6^ gram1 microgram = 1 mcg or 1 µg1 milligram = 0.001 gram1 milligram = 1 mg1 centigram = 0.01 gram1 centigram = 1 cg1 decigram = 0.1 gram1 decigram = 1 dg1 gram1 gram = 1 g1 kilogram = 1000 grams1 kilogram = 1 kgThe standard unit of length in the metric system is the meter.1 millimeter = 0.001 meter1 millimeter = 1 mm1 centimeter = 0.01 meter1 centimeter = 1 cm1 meter1 meter = 1 m1 decimeter = 0.1 meter1 decimeter = 1 dm1 kilometer = 1000 meters1 kilometer = 1 km[^11]

Table 6-16Vaccines Licensed for Use in Dogs in the United StatesVaccine TypeCore versus\
NoncoreRecommended Vaccination Interval for Administration of Booster InoculationsMinimum Duration of ImmunityDistemper: modified live (parenteral)Core3 years5+ to 7+ years (depending on strain)Recombinant distemper (parenteral)Core3 years5+ yearsMeasles virus: modified live (parenteral)\
Available only in combination with modified live distemper + adenovirus-2 + parainfluenza vaccineNoncoreNot indicatedNot applicableParvovirus: modified live (parenteral)Core3 years7+ yearsCoronavirus: modified live (parenteral)NRNRCannot be determinedCoronavirus: killed (parenteral)NRNRCannot be determinedCanine adenovirus-2: modified live (parenteral)Core3 years7+ yearsCanine adenovirus-2: modified live (intranasal)Core3 years3+ years\
*Note:* the intranasal vaccine is not intended for the prevention of canine hepatitis virus infection.Canine adenovirus-2: killed (parenteral)NoncoreAnnualUnknownParainfluenza virus: modified live (parenteral)Noncore3 years3+ yearsParainfluenza virus: modified live (intranasal)Noncore3 years3+ years (preferred)*Bordetella bronchiseptica:* avirulent live (intranasal)NoncoreAnnual12 months*B. bronchiseptica:* antigen extract (parenteral)NoncoreAnnualNot establishedCanine influenza virus: killed (parenteral)NoncoreAnnualNot establishedLeptospira var canicola\
Leptospira var icterhemorrhagiae\
Leptospira var pomona\
Leptospira var grippotyphosaNon-core\
Non-core\
Non-core\
Non-coreAnnual\
Annual\
Annual\
Annual12 monthsRecombinant Lyme (parenteral)NoncoreAnnual1 yearLyme: killed (parenteral)NoncoreAnnual1 year*Crotalus atrox* (rattlesnake vaccine)NoncoreAnnual or seasonally as recommended by manufacturerUnknown (license is conditional at this writing---challenge studies in dogs have not been performed)Rabies, 1-year: killed (parenteral)CoreAs defined by local and state law3+ yearsRabies, 3-year: killed (parenteral)CoreAs defined by local and state law3+ years[^12]

Table 6-17Vaccines Licensed for Use in Cats in the United StatesVaccine TypeAdjuvanted versus\
NonadjuvantedCore versus\
NoncoreRecommended Vaccination\
Interval for Administration of Booster InoculationsMinimum Duration of ImmunityPanleukopenia: modified live (parenteral)NonadjuvantedCore3 years7 + yearsPanleukopenia: killed (parenteral)AdjuvantedNoncoreAnnual5 + yearsPanleukopenia: modified live (intranasal)NonadjuvantedNoncore3 yearsNot establishedHerpesvirus-calicivirus: modified live (parenteral)NonadjuvantedCore3 years (annual vaccination may be recommended in high-risk settings)5 + yearsHerpesvirus-calicivirus: killed (parenteral)AdjuvantedNoncoreAnnual5 + yearsHerpesvirus-calicivirus: modified live (intranasal)NonadjuvantedNoncoreAnnualNot established*Chlamydophilia felis:* killedAdjuvantedNoncoreAnnual1 year (maximum)*C. felis:* live, avirulentNonadjuvantedNoncoreAnnualRecombinant feline leukemia virus (transdermal in the United States; parenteral in Canada, the United Kingdom, and Europe)NonadjuvantedNoncore[\*](#tf0055){ref-type="table-fn"}Annual where risk is sustained1 yearFeline leukemia virus: killed (parenteral)AdjuvantedNoncore[\*](#tf0055){ref-type="table-fn"}Annual where risk is sustained1 yearFeline immunodeficiency virus: killed (parenteral)AdjuvantedNon-core^†^Annual1 yearFeline infectious peritonitis: modified live (intranasal)NonadjuvantedNRNRNot established*Bordetella bronchiseptica:* modified live (intranasal)NonadjuvantedNoncoreAnnual1 yearVirulent systemic feline calicivirus: killed (parenteral)AdjuvantedNoncoreAnnual1 yearRecombinant rabies (parenteral)NonadjuvantedCoreAnnual1+ years (must be administered in accordance with state and local requirements)Rabies, 1-year: killed (parenteral)AdjuvantedCoreAnnual3+ years (must be administered in accordance with state and local requirements)Rabies, 3-year: killed (parenteral)AdjuvantedCore3 years (as required by law)3+ years (must be administered in accordance with state and local requirements)[^13][^14]

Table 6-18Canine Vaccination Recommendations---Initial Puppy SeriesAdministrationBoosterC[ore vaccines]{.smallcaps}MLV or rDistemper +\
MLV Parvovirus +\
MLV Adenovirus-28 wk, 12 wk, and 16 wk of ageNot later than 1 year after the last dose in the initial seriesOption:\
Parainfluenza virus is often administered in combination with the above vaccines.When parainfluenza virus vaccine is indicated, intranasal vaccination (which is combined with *Bordetella bronchiseptica*) is recommended.Rabies, 1-year (killed)Single dose usually given at 12 or 16 wk (local or state statutes apply)Single dose of a rabies 3-year vaccineN[oncore vaccines]{.smallcaps}*B. bronchiseptica* + parainfluenza virus (intranasal)Single dose (intranasal) at 12 or 16 wk of age. (Optional: some authors recommend 2 doses at 12 and 16 wk of age.)When risk of exposure exists, administer a single dose 1 year after the last dose administered.*Leptospira* (killed) four-serovar \[two-way *Leptospira* vaccines are no longer recommended\]Two initial doses, 2 to 4 wk apart\
*Note:* Do not administer the first dose before 12 wk of age.\
*Also:* In small-breed dogs, delay initial administration until 2 to 4 wk after completion of the initial core series.When risk of exposure exists, administer a single dose 1 year after the last dose administered.Lyme disease\
(recombinant or killed)Two initial doses, 2 to 4 wk apart\
*Note:* Do not administer the first dose before 12 wk of age.\
*Also:* In small-breed dogs, delay initial administration until 2 to 4 wk after completion of the initial core series.When risk of exposure exists, administer a single dose 1 year after the last dose administered.Canine influenza virus (killed)Two initial doses, 2 to 4 wk apart\
*Note:* Do not administer the first dose before 12 wk of age.\
*Also:* In small-breed dogs, delay initial administration until after completion of the initial core series.Indication for vaccination depends on individual patient exposure risk.\
Duration of immunity has not been established at this writing.\
Manufacturer recommends annual revaccination when risk of exposure exists.*Crotalus atrox*The decision to use this vaccine is dependent on individual patient risk for exposure to the Western Diamondback Rattlesnake. Administration recommendations may vary depending on the level of risk and patient size.[^15]

Table 6-19Canine Vaccination Recommendations---AdultC[anine core vaccines]{.smallcaps}•A single booster dose of combination distemper + parvovirus + adenovirus-2 vaccine is recommended every 3 years.•Rabies vaccine is administered in accordance with state or local requirements. All states currently recognize the 3-year rabies vaccine for dogs. Some municipalities or counties may require rabies vaccine to be administered more frequently than every 3 years. Some States allow discretionary use of a labeled 3-year rabies in place of a labeled 1-year rabies vaccine.C[anine non-core vaccines]{.smallcaps}•Administer a single dose annually to patients with sustained exposure risk.•Patients that have not been vaccinated within the past 2 years should receive two doses of a noncore vaccine, 2 to 6 weeks apart. The exception is the intranasal *Bordetella bronchiseptica* + parainfluenza virus (+ adenovirus-2) vaccines, in which a single dose is considered sufficient to induce a protective immune response regardless of the time since administration of the last vaccine.

Table 6-20Feline Vaccination Recommendations---Initial Kitten SeriesAdministrationBoosterC[ore vaccines]{.smallcaps}MLV panleukopenia + MLV herpesvirus + MLV calicivirus\
When feasible, avoid the use of killed (adjuvanted) vaccines in cats.Single dose at 8 wk, 12 wk, and 16 wk of ageNot later than 1 year after the last dose in the initial series.Rabies (recombinant \[the only nonadjuvanted rabies vaccine\])\
Alternative: rabies (killed-adjuvanted)Single dose usually given at 12 or 16 wk of age (state or local law applies)Administer a single dose of rabies vaccine within 1 year after administration of the initial dose.N[oncore vaccines]{.smallcaps}Feline leukemia virus (FeLV)\
Recombinant-nonadjuvanted (also available as killed-adjuvanted)Highly recommended for all kittens: one dose at 12 and 16 wk of ageWhen risk of exposure exists, administer a single dose 1 year after the last dose administered.Feline immunodeficiency virus (FIV)\
Killed-adjuvantedThree initial doses 2 to 4 weeks apart, if indicated*Note:* Initial vaccination will cause cats to have a false-positive FIV test result on *all* commercial FIV tests for at least 1 year. Kittens having nursed from a vaccinated cat may also have a false-positive test result.Feline *Bordetella bronchiseptica*\
Attenuated live intranasalA single dose, administered intranasally as early as 4 weeks of age, if indicatedWhen risk of exposure exists, administer a single dose 1 year after the last dose administered.Feline *Chlamydophila feli*s (formerly *Chlamydia psittaci*)Two initial doses 3 to 4 weeks apart, if indicatedBooster annually if risk of exposure is clear (exposure risk among household cats is very low).Virulent systemic (VS) calicivirus\
Killed-adjuvantedTwo initial doses 2 to 4 weeks apart, if indicatedDisease prevalence is considered low and limited to cluster environments (especially shelters).[^16][^17]

Table 6-21Feline Vaccination Recommendations---AdultVaccineAdministrationC[ore vaccines]{.smallcaps}MLV panleukopenia + MLV herpesvirus +\
MLV calicivirus\
When feasible, avoid the use killed (adjuvanted) vaccines in cats.Administer a single dose every 3 years after completion of the initial kitten series and the first booster.Rabies (recombinant \[the only nonadjuvanted rabies vaccine\])\
*or*\
Rabies (killed-adjuvanted)Administer a single dose annually in accordance with State or local law.N[oncore vaccines]{.smallcaps}[\*](#tf0060){ref-type="table-fn"}Feline leukemia virus (FeLV)\
Recombinant-nonadjuvanted\
(also available as killed-adjuvanted)FeLV vaccination recommended annually *only* if risk is sustained (e.g., outdoor cats with reasonable risk of encounter with other cats). The recombinant FeLV vaccine (administered transdermally) is not adjuvanted; all other FeLV vaccines contain adjuvant.[^18][^19]

Table 6-22Compendium of Animal Rabies Prevention and Control, 2005,[\*](#tf9000){ref-type="table-fn"} National Association of State Public Health Veterinarians (NASPHV)[†](#tf9005){ref-type="table-fn"}Rabies is a fatal viral zoonosis and a serious public health problem.[@bb0010] The recommendations in this compendium serve as the basis for animal rabies prevention and control programs throughout the United States and facilitate standardization of procedures among jurisdictions, thereby contributing to an effective national rabies-control program. This document is reviewed annually and revised as necessary. Principles of rabies prevention and control are detailed in Part I; Part II contains recommendations for parenteral vaccination procedures. All animal rabies vaccines licensed by the U.S. Department of Agriculture (USDA) and marketed in the United States are listed in Part III.**P[art]{.smallcaps} I: R[abies prevention and control]{.smallcaps}**A.Principles of rabies prevention and control1.Rabies exposure. Rabies is transmitted only when the virus is introduced into bite wounds, into open cuts in skin, or onto mucous membranes from saliva or other potentially infectious material such as neural tissue.[@bb0015] Questions about possible exposures should be directed to state or local health authorities.2.Human rabies prevention. Rabies in humans can be prevented either by eliminating exposures to rabid animals or by providing exposed persons with prompt local treatment of wounds combined with the administration of human rabies immune globulin and vaccine. The rationale for recommending preexposure and postexposure rabies prophylaxis and details of their administration can be found in the current recommendations of the Advisory Committee on Immunization Practices (ACIP).[@bb0015] These recommendations, along with information concerning the current local and regional epidemiology of animal rabies and the availability of human rabies biologics, are available from state health departments.3.Domestic animals. Local governments should initiate and maintain effective programs to ensure vaccination of all dogs, cats, and ferrets and to remove strays and unwanted animals. Such procedures in the United States have reduced laboratory-confirmed cases of rabies in dogs from 6949 in 1947 to 117 in 2003.[@bb0020] Because more rabies cases are reported annually involving cats (321 in 2003) than dogs, vaccination of cats should be required. Animal shelters and animal control authorities should establish policies to ensure that adopted animals are vaccinated against rabies. The recommended vaccination procedures and the licensed animal vaccines are specified in Parts II and III of the compendium.4.Rabies in vaccinated animals. Rabies is rare in vaccinated animals.[@bb0025] If such an event is suspected, it should be reported to state public health officials; the vaccine manufacturer; and USDA, Animal and Plant Health Inspection Service, Center for Veterinary Biologics ([www.aphis.usda.gov/vs/cvb/ic/adverseeventreport.htm;](http://www.aphis.usda.gov/vs/cvb/ic/adverseeventreport.htm;){#ir0065} telephone 800-752-6255; or <CVB@usda.gov>). The laboratory diagnosis should be confirmed and the virus characterized by a rabies reference laboratory. A thorough epidemiologic investigation should be conducted.5.Rabies in wildlife. The control of rabies among wildlife reservoirs is difficult.[@bb0030] Vaccination of free-ranging wildlife or selective population reduction might be useful in some situations, but the success of such procedures depends on the circumstances surrounding each rabies outbreak (see Part I. C. Prevention and Control Methods Related to Wildlife). Because of the risk of rabies in wild animals (especially raccoons, skunks, coyotes, foxes, and bats), AVMA, NASPHV, and CSTE strongly recommend the enactment and enforcement of state laws prohibiting their importation, distribution, and relocation.6.Rabies surveillance. Laboratory-based rabies surveillance is an essential component of rabies control and prevention programs. Accurate and timely information is necessary to guide human postexposure prophylaxis decisions, determine the management of potentially exposed animals, aid in emerging pathogen discovery, describe the epidemiology of the disease, and assess the need for and effectiveness of oral vaccination programs for wildlife.7.Rabies diagnosis. Rabies testing should be performed by a qualified laboratory that has been designated by the local or state health department[@bb0035] in accordance with the established national standardized protocol for rabies testing ([www.cdc.gov/ncidod/dvrd/rabies/Professional/publications/DFA_diagnosis/DFA_protocol-b.htm](http://www.cdc.gov/ncidod/dvrd/rabies/Professional/publications/DFA_diagnosis/DFA_protocol-b.htm){#ir0070}). Euthanasia[@bb0040] should be accomplished in such a way as to maintain the integrity of the brain so that the laboratory can recognize the anatomic parts. Except in the case of very small animals, such as bats, only the head or brain (including brainstem) should be submitted to the laboratory. Any animal or animal specimen being submitted for testing should be kept under refrigeration (not frozen or chemically fixed) during storage and shipping.8.Rabies serology. Some "rabies-free" jurisdictions may require evidence of vaccination and rabies antibodies for importation purposes. Rabies antibody titers are indicative of an animal\'s response to vaccine or infection. Titers do not directly correlate with protection because other immunologic factors also play a role in preventing rabies, and our abilities to measure and interpret those other factors are not well developed. Therefore, evidence of circulating rabies virus antibodies should not be used as a substitute for current vaccination in managing rabies exposures or determining the need for booster vaccinations in animals.[@bb0045]B.Prevention and control methods in domestic and confined animals1.Preexposure vaccination and management. Parenteral animal rabies vaccines should be administered only by or under the direct supervision of a veterinarian. Rabies vaccinations may also be administered under the supervision of a veterinarian to animals held in animal control shelters before release. Any veterinarian signing a rabies certificate must ensure that the person administering vaccine is identified on the certificate and is appropriately trained in vaccine storage, handling, and administration and in the management of adverse events. This practice ensures that a qualified and responsible person can be held accountable to ensure that the animal has been properly vaccinated.Within 28 days after primary vaccination, a peak rabies antibody titer is reached and the animal can be considered immunized. An animal is currently vaccinated and is considered immunized if the primary vaccination was administered at least 28 days previously and vaccinations have been administered in accordance with this compendium.Regardless of the age of the animal at initial vaccination, a booster vaccination should be administered 1 year later (see Parts II and III for vaccines and procedures). No laboratory or epidemiologic data exist to support the annual or biennial administration of 3-year vaccines following the initial series. Because a rapid anamnestic response is expected, an animal is considered currently vaccinated immediately after a booster vaccination.a.Dogs, cats, and ferrets. All dogs, cats, and ferrets should be vaccinated against rabies and revaccinated in accordance with Part III of this compendium. If a previously vaccinated animal is overdue for a booster, it should be revaccinated. Immediately after the booster, the animal is considered currently vaccinated and should be placed on an annual or triennial schedule depending on the type of vaccine used.b.Livestock. Consideration should be given to vaccinating livestock that are particularly valuable or that might have frequent contact with humans (e.g., in petting zoos, fairs, and other public exhibitions).[@bb0050] [@bb0055] Horses traveling interstate should be currently vaccinated against rabies.c.Confined animals.1)Wild. No parenteral rabies vaccines are licensed for use in wild animals or hybrids (the offspring of wild animals crossbred to domestic animals). Wild animals or hybrids should not be kept as pets.[@bb0060], [@bb0065], [@bb0070], [@bb0075]2)Maintained in exhibits and in zoologic parks. Captive mammals that are not completely excluded from all contact with rabies vectors can become infected. Moreover, wild animals might be incubating rabies when initially captured; therefore, wild-caught animals susceptible to rabies should be quarantined for a minimum of 6 months before being exhibited. Employees who work with animals at such facilities should receive preexposure rabies vaccination. The use of preexposure or postexposure rabies vaccinations for employees who work with animals at such facilities might reduce the need for euthanasia of captive animals. Carnivores and bats should be housed in a manner that precludes direct contact with the public.3)Stray animals. Stray dogs, cats, and ferrets should be removed from the community. Local health departments and animal control officials can enforce the removal of strays more effectively if owned animals have identification and are confined or kept on leash. Strays should be impounded for at least 3 business days to determine if human exposure has occurred and to give owners sufficient time to reclaim animals.2.Importation and interstate movement of animals.a.International. The CDC regulates the importation of dogs and cats into the United States. Importers of dogs must comply with rabies vaccination requirements (42 CFR, Part 71.51\[c\] \[[www.cdc.gov/ncidod/dq/animal.htm](http://www.cdc.gov/ncidod/dq/animal.htm){#ir0075}\]) and complete CDC form 75.37 ([www.cdc.gov/ncidod/dq/pdf/cdc7537-05-24-04.pdf](http://www.cdc.gov/ncidod/dq/pdf/cdc7537-05-24-04.pdf){#ir0080}). The appropriate health official of the state of destination should be notified within 72 hours of the arrival into his or her jurisdiction of any imported dog required to be placed in confinement under the CDC regulation. Failure to comply with these requirements should be promptly reported to the Division of Global Migration and Quarantine, CDC (telephone 404-498-1670).Federal regulations alone are insufficient to prevent the introduction of rabid animals into the country.[@bb0080] ^,^ [@bb0085] All imported dogs and cats are subject to state and local laws governing rabies and should be currently vaccinated against rabies in accordance with this compendium. Failure to comply with state or local requirements should be referred to the appropriate state or local official.b.Interstate. Before interstate (including commonwealths and territories) movement, dogs, cats, ferrets, and horses should be currently vaccinated against rabies in accordance with the compendium\'s recommendations (see Part I. B.1. Preexposure Vaccination and Management). Animals in transit should be accompanied by a currently valid NASPHV Form 51, Rabies Vaccination Certificate ([www.nasphv.org/83416/106001.html](http://www.nasphv.org/83416/106001.html){#ir0085}). When an interstate health certificate or certificate of veterinary inspection is required, it should contain the same rabies vaccination information as Form 51.c.Areas with dog-to-dog rabies transmission. The movement of dogs from areas with dog-to-dog rabies transmission for the purpose of adoption or sale should be eliminated. Rabid dogs have been introduced into the United States from areas with dog-to-dog rabies transmission.[@bb0080] ^,^ [@bb0085] This practice poses the risk of introducing canine-transmitted rabies to areas where it does not currently exist. 3.Adjunct procedures. Methods or procedures that enhance rabies control include the following:a.Identification. Dogs, cats, and ferrets should be identified (e.g., metal or plastic tags or microchips) to allow for verification of rabies vaccination status.b.Licensure. Registration or licensure of all dogs, cats, and ferrets may be used to aid in rabies control. A fee is frequently charged for such licensure, and revenues collected are used to maintain rabies- or animal-control programs. Evidence of current vaccination is an essential prerequisite to licensure.c.Canvassing. House-to-house canvassing by animal control officials facilitates enforcement of vaccination and licensure requirements.d.Citations. Citations are legal summonses issued to owners for violations, including the failure to vaccinate or license their animals. The authority for officers to issue citations should be an integral part of each animal-control program.e.Animal control. All communities should incorporate stray animal control, leash laws, and training of personnel in their programs.4.Postexposure management. Any animal potentially exposed to rabies virus (see Part I. A.1. Rabies Exposure) by a wild, carnivorous mammal or a bat that is not available for testing should be regarded as having been exposed to rabies.a.Dogs, cats, and ferrets. Unvaccinated dogs, cats, and ferrets exposed to a rabid animal should be euthanized immediately. If the owner is unwilling to have this done, the animal should be placed in strict isolation for 6 months. Rabies vaccine should be administered on entry into isolation or 1 month before release to comply with preexposure vaccination recommendations (see Part I. B.1.a.). Protocols for the postexposure vaccination of previously unvaccinated domestic animals have not been validated, and evidence exists that the use of vaccine alone will not prevent the disease.[@bb0090] Animals with expired vaccinations need to be evaluated on a case-by-case basis. Dogs, cats, and ferrets that are currently vaccinated should be revaccinated immediately, kept under the owner\'s control, and observed for 45 days. Any illness in an isolated or confined animal should be reported immediately to the local health department.b.Livestock. All species of livestock are susceptible to rabies; cattle and horses are among the most frequently infected. Livestock exposed to a rabid animal and currently vaccinated with a vaccine approved by USDA for that species should be revaccinated immediately and observed for 45 days. Unvaccinated livestock should be slaughtered immediately. If the owner is unwilling to have this done, the animal should be kept under close observation for 6 months. Any illness in an animal under observation should be reported immediately to the local health department.The following are recommendations for owners of livestock exposed to rabid animals:1)If the animal is slaughtered within 7 days of being bitten, its tissues may be eaten without risk of infection, provided that liberal portions of the exposed area are discarded. Federal guidelines for meat inspectors require that any animal known to have been exposed to rabies within 8 months be rejected for slaughter.2)Neither tissues nor milk from a rabid animal should be used for human or animal consumption.[@bb0095] Pasteurization temperatures will inactivate rabies virus; therefore, drinking pasteurized milk or eating cooked meat does not constitute a rabies exposure.3)Having more than one rabid animal in a herd or having herbivore-to-herbivore transmission is uncommon; therefore restricting the rest of the herd if a single animal has been exposed to or infected by rabies might not be necessary.c.Other animals. Other mammals bitten by a rabid animal should be euthanized immediately. Animals maintained in USDA-licensed research facilities or accredited zoologic parks should be evaluated on a case-by-case basis.5.Management of animals that bite humans.a.Dogs, cats, and ferrets. Rabies virus may be excreted in the saliva of infected dogs, cats, and ferrets during illness and/or for only a few days before illness or death.[@bb0100] ^,^ [@bb0105] ^,^ [@bb0110] A healthy dog, cat, or ferret that bites a person should be confined and observed daily for 10 days[@bb0115]; administration of rabies vaccine to the animal is not recommended during the observation period to avoid confusing signs of rabies with possible side effects of vaccine administration.Such animals should be evaluated by a veterinarian at the first sign of illness during confinement. Any illness in the animal should be reported immediately to the local health department. If signs suggestive of rabies develop, the animal should be euthanized and the head shipped for testing as described in Part I. A.7. Any stray or unwanted dog, cat, or ferret that bites a person may be euthanized immediately and the head submitted for rabies examination.b.Other biting animals. Other biting animals that might have exposed a person to rabies should be reported immediately to the local health department. Management of animals other than dogs, cats, and ferrets depends on the species, the circumstances of the bite, the epidemiology of rabies in the area, and the biting animal\'s history, current health status, and potential for exposure to rabies. Prior vaccination of these animals may not preclude the necessity of euthanasia and testing. C.Prevention and control methods related to wildlife.The public should be warned not to handle or feed wild mammals. Wild mammals and hybrids that bite or otherwise expose persons, pets, or livestock should be considered for euthanasia and rabies examination. A person bitten by any wild mammal should immediately report the incident to a physician who can evaluate the need for antirabies treatment (see current rabies prophylaxis recommendations of the ACIP[@bb0015]). State-regulated wildlife rehabilitators may play a role in a comprehensive rabies control program. Minimum standards for persons who rehabilitate wild mammals should include rabies vaccination, appropriate training, and continuing education. Translocation of infected wildlife has contributed to the spread of rabies[@bb0120] ^,^ [@bb0125]; therefore the translocation of known terrestrial rabies reservoir species should be prohibited.1.Terrestrial mammals. The use of licensed oral vaccines for the mass vaccination of free-ranging wildlife should be considered in selected situations, with the approval of the state agency responsible for animal rabies control.[@bb0030] The distribution of oral rabies vaccine should be based on scientific assessments of the target species and followed by timely and appropriate analysis of surveillance data; such results should be provided to all stakeholders. In addition, parenteral vaccination (trap-vaccinate-release) of wildlife rabies reservoirs may be integrated into coordinated oral rabies vaccination programs to enhance their effectiveness. Continuous and persistent programs for trapping or poisoning wildlife are not effective in reducing wildlife rabies reservoirs on a statewide basis. However, limited population control in high-contact areas (e.g., picnic grounds, camps, suburban areas) may be indicated for the removal of selected high-risk species of wildlife.[@bb0030] State agriculture, public health, and wildlife agencies should be consulted for planning, coordination, and evaluation of vaccination or population-reduction programs.2.Bats. Indigenous rabid bats have been reported from every state except Hawaii and have caused rabies in at least 40 humans in the United States.[@bb0130] ^-^ [@bb0150] Bats should be excluded from houses, public buildings, and adjacent structures to prevent direct association with humans.[@bb0155] ^,^ [@bb0160] Such structures should then be made bat-proof by sealing entrances used by bats. Controlling rabies in bats through programs designed to reduce bat populations is neither feasible nor desirable.**P[art]{.smallcaps} II: R[ecommendations for parenteral rabies vaccination procedures]{.smallcaps}**A.Vaccine administrationAll animal rabies vaccines should be restricted to use by, or under the direct supervision of, a veterinarian[@bb0165] except as recommended in Part I. B.1. All vaccines must be administered in accordance with the specifications of the product label or package insert.B.Vaccine selectionPart III lists all vaccines licensed by USDA and marketed in the United States at the time of publication. New vaccine approvals or changes in label specifications made subsequent to publication should be considered as part of this list. Any of the listed vaccines can be used for revaccination, even if the product is not the same brand previously administered. Vaccines used in state and local rabies control programs should have a 3-year duration of immunity. This constitutes the most effective method of increasing the proportion of immunized dogs and cats in any population.[@bb0170] No laboratory or epidemiologic data exist to support the annual or biennial administration of 3-year vaccines following the initial series.C.Adverse eventsCurrently, no epidemiologic association exists between a particular licensed vaccine product and adverse events, including vaccine failure.[@bb0175] ^,^ [@bb0180] Adverse events should be reported to the vaccine manufacturer and to USDA, Animal and Plant Health Inspection Service, Center for Veterinary Biologics ([www.aphis.usda.gov/vs/cvb/ic/adverseeventreport.htm;](http://www.aphis.usda.gov/vs/cvb/ic/adverseeventreport.htm;){#ir0090} telephone 800-752-6255; or e-mail CVB\@usda.gov).D.Wildlife and hybrid animal vaccinationThe safety and efficacy of parenteral rabies vaccination of wildlife and hybrids have not been established, and no rabies vaccines are licensed for these animals. Parenteral vaccination (trap-vaccinate-release) of wildlife rabies reservoirs may be integrated into coordinated oral rabies vaccination programs as described in Part I. C.1. to enhance their effectiveness. Zoos or research institutions may establish vaccination programs, which attempt to protect valuable animals, but these should not replace appropriate public health activities that protect humans.[@bb0050]E.Accidental human exposure to vaccineHuman exposure to parenteral animal rabies vaccines listed in Part III does not constitute a risk for rabies infection. However, human exposure to vaccinia-vectored oral rabies vaccines should be reported to state health officials.[@bb0185]F.Rabies certificateAll agencies and veterinarians should use NASPHV Form 51, Rabies Vaccination Certificate, which can be obtained from vaccine manufacturers or from NASPHV ([www.nasphv.org](http://www.nasphv.org){#ir0095}). It is also available from CDC ([www.cdc.gov/ncidod/dvrd/rabies/professional/professi.htm](http://www.cdc.gov/ncidod/dvrd/rabies/professional/professi.htm){#ir0100}). The form must be completed in full and signed by the administering or supervising veterinarian. Computer-generated forms containing the same information are also acceptable.[^20][^21]

Table 6-23Prescription Writing Reference: Do\'s and Don\'tsVeterinarian InformationOwner InformationA[lways include]{.smallcaps}:Prescribing veterinarian\'s namePatient\'s name (in "quotes")Practice addressPatient\'s age or date of birthPractice telephone numberOwner\'s name (or that of an owner representative)DEA \# (if written for a controlled substance)Owner\'s addressCurrent dateOwner\'s phone numberP[rescription]{.smallcaps}•Drug name: Print *full* brand name or generic name; *never* abbreviate•Dosage form: Specify tablet, capsule, suspension, other•Strength (e.g., mg, g, mcg) or concentration (mg/mL); use metric units•Total quantity (\# 10 \[for 10 tablets\]; 60 mL)•Sig: Include the following: dose (individual); route; frequency; duration; indication or use•Number of refills: Define the number permitted•Designate whether or not generic substitution is permissible•SignatureC[ommon prescription writing errors]{.smallcaps}•Always use metric units: for example, g (gram) for solids; mL (milliliter) for liquids.•Use *per* instead of a slash (/), which can be interpreted as the number 1.•Use *units* instead of the abbreviation *u,* which can be interpreted as 0 or 4 or µ.•Use *once daily* instead of *sid,* which has been interpreted as 5/d, or 5 per day! (*Note:* "sid" is not a conventional prescription abbreviation.)•Use *three times daily* instead of *tid,* and *four times daily* instead of *qid.*•Use *every other day* instead of *qod.*•*Remember:* Abbreviations such as *qd, qid,* and *qod* are easily confused with one another.•When writing numbers:•Use a leading zero with decimals: for example, use 0.5 mL rather than .5 mL.•Avoid using a trailing zero: for example, use 3 rather than 3.0.•And *finally*---When in doubt, spell it out.

Table 6-24Common Drug Indications and Dosages[\*](#tf0065){ref-type="table-fn"}DrugProprietary NamesAction and UseFormulationRecommended DosageAcepromazineMany generic productsTranquilizer and antiemetic5-, 10-, and 25-mg tablets and 10-mg/mL injectionDog: 0.56-1.13 mg/kg IM, SQ, IV; 0.56-2.25 mg/kg PO q6-8h\
Cat: 1.13-2.25 mg/kg IM, SQ, IVAcetaminophenTylenol and other generic brandsNSAID; analgesia120-, 160-, 325-, and 500-mg tabletsDog: 15 mg/kg PO q8h\
Cat: *Do not use*Acetaminophen with codeineTylenol with codeine, other generic productsNSAID + opioid; analgesiaOral solution and tablets\
Many forms (e.g., 300 mg acetaminophen plus 15, 30, or 60 mg codeine)Follow dosing recommendations for codeine\
Dog: (analgesia) 0.5-1 mg/kg PO q6-8h\
Cat: *Do not use*AcetazolamideDiamoxDiuretic; management of glaucoma125- and 250-mg tabletsGlaucoma: 5-10 mg/kg PO q8-12h\
Diuretic: 4-8 mg/kg PO q8-12h§ AcetylcysteineMucomystAntidote; acetaminophen toxicosis in cats20% solution (200 mg/mL)Cat (acetaminophen toxicosis): 140 mg/kg (initial loading dose); then 70 mg/kg PO or IV q4h for five dosesACTH gelSee *Corticotropin*Activated charcoalActaChar, Charcodote, ToxiBan, and genericGI adsorbentOral suspension1-4 g/kg PO (granules)\
6-12 mL/kg (suspension)AlbendazoleValbazenAntiparasitic, especially respiratory parasites and *Giardia* species113.6-mg/mL suspension and 300-mg/mL pasteGeneral antiparasitic: 25-50 mg/kg PO q12h for 3--5-days\
Respiratory parasites: 50 mg/kg, q24h PO for 10-14 days\
*Giardia:* 25 mg/kg q12h for 2--5-days;\
2 to 5 puffs four times dailyAlbuterolProventil, VentolinBronchodilator2-, 4-, and 5-mg tablets; 2 mg/5 mL syrup; aerosol (metered inhaler at 90 mcg/dose)20-50 mcg/kg four times per day; up to\
maximum of 100 mcg/kg four times per dayAllopurinolLopurin, ZyloprimAntiinflammatory; adjunct therapy for leishmaniasis; urolith prevention100- and 300-mg tabletsUrolith prevention: 10 mg/kg q8h; then reduce to 10 mg/kg q24h\
Leishmaniasis: 10 mg/kg q12h PO for 4 months or moreAluminum carbonate gelBasaljelAntacid, GI phosphate binder (uncommonly used today)Capsules (equivalent to 500 mg aluminum hydroxide)10-30 mg/kg PO q8h (with meals)Aluminum hydroxide gelAmphojelAntacid, GI phosphate binder (uncommonly used today)64 mg/mL oral suspension; 600-mg tablet10-90 mg/kg PO q8h (with meals)AmikacinAmiglyde-V (veterinary), Amikin (human)Antibacterial50- and 250-mg/mL injectionDog: 15-30 mg/kg, IV, IM, SQ, q24h\
Cat: 10-14 mg/kg, IV, IM, SQ, q24hAminophyllineMany generic brandsBronchodilator; chronic bronchitis and asthma100- and 200-mg tablets; 25 mg/mL injectionDog: 5-11 mg/kg PO, IM, IV q8-12h\
Cat: 6.6 mg/kg PO q12h§ AmiodaroneCordaroneAntiarrhythmic; life-threatening arrhythmias200-mg tablet and 50 mg/mL injectionDog: 10-15 mg/kg PO q12h, up to 1 wk; then 5-7.5 mg/kg PO q12h for 2 wk; then 7.5 mg/kg q24h as maintenance\
Cat: no dosage recommendationAmitrazMitabanAntiparasitic, especially ectoparasites: *Demodex* and *Sarcoptes*10.6 mL concentrated dip (19.9%)10.6 mL per 7.5 L water (0.025% solution); apply three to six topical treatments every 2 weeks for refractory cases; this dose has been exceeded to produce increased efficacy. Doses used have included 0.025%, 0.05%, and 0.1% concentration applied twice a week and 0.125% solution applied to one-half body every day for 4 weeks to 5 months.AmitriptylineElavilBehavior modifier; separation anxiety and (in cats) chronic idiopathic cystitis10-, 25-, 50-, 75-, 100-, and 150-mg tablets; 10 mg/mL injectionDog: 1-2 mg/kg PO q12-24h (range 0.25-4 mg/kg q12-24h)\
Cat: 0.5-2 mg/kg q12-24h or approximately 5-10 mg per cat per day POAmlodipineNorvascCalcium channel blocker, vasodilator for systemic hypertension2.5-, 5-, and 10-mg tabletsDog: 2.5 mg/dog or 0.1-0.4 mg/kg PO q12-24h\
Cat: 0.625 mg/cat/day PO initially; then increase if needed to 1.25 mg/cat/day (average is 0.18 mg/kg once daily)Ammonium chlorideGenericUrinary acidifier; acidifies urine and treats metabolic alkalosisAvailable as crystalsDog: 200 mg/kg/day divided TID-QID\
Cat: 800 mg/cat (approximately ⅓ to ¼ tsp)\
mixed with food dailyAmoxicillin trihydrateAmoxi-Tabs,\
Amoxi-Drops,\
Amoxil, othersBroad-spectrum antibacterial50-, 100-, 200-, and 400-mg tablets; 50 mg/mL oral suspension6-20 mg/kg PO q8-12hAmoxicillin- clavulanateClavamoxBroad-spectrum antibacterial62.5-, 125-, 250-, and 375-mg tablets; 62.5 mg/mL suspensionDog: 12.5-15 mg/kg PO q12h\
Cat: 62.5 mg/cat PO q12h; consider administering these doses q8h for gram-negative infectionsAmphotericin BAmBisome (new formulation; less toxic but expensive)Antifungal (liposomal formulation); deep, systemic fungal infection and leishmaniasis50-mg injectable vial3-5 mg/kg/day IV administered over 60-120 minutes for 3 days per week (cumulative dose = 24-27 mg/kg)Fungizone (traditional formulation)Antifungal; deep systemic fungal infection and leishmaniasis50-mg injectable vial0.5 mg/kg IV (slow infusion) q48h; cumulative dose is 4-8 mg/kg\
*Caution:* Monitor renal function.AmpicillinOmnipen, Principen, othersBroad-spectrum antibacterial250- and 500-mg capsules; 125-, 250-, and 500-mg vials of ampicillin sodium10-20 mg/kg IV, IM, SQ q6-8h (ampicillin sodium); 20-40 mg/kg PO q8h§ Ampicillin + sulbactamUnasynBroad-spectrum antibacterial1.5- and 3-g vials in 2:1 combination for injection20-50 mg/kg (total combined) IV, IM q8hAmpicillin trihydratePolyflexBroad-spectrum antibacterial10- and 25-mg vials for injection6.5-22 mg/kg IM, SQ q12hAmproliumAmprol, CoridThiamine analogue; treatment for coccidia9.6% (9.6 g/dL) oral solution; soluble powder1.25 g of 20% amprolium powder to daily feed, or 30 mL of 9.6% amprolium solution to 3.8 L of drinking water for 7 days§ Antiserum, snakebiteAntiveninAntivenin, concentrated serum globulin from horses immunized with multiple types of venom10-mL vialsDose varies from 10 to 50 mL (1 to 5 vials) initially; additional doses may be administered q2h after initial treatment§ ApomorphineGenericEmetic (potent)6-mg tablets0.02-0.04 mg/kg IV, IM, 0.1 mg/kg SQ, or instill 0.25 mg in conjunctiva of eye (dissolve 6-mg tablet in 1-2 mL of saline)Ascorbic acidVitamin CVitamin supplementVarious forms100-500 mg/animal/day (diet supplement) or 100 mg/animal q8h (urine acidification)[l]{.smallcaps}-AsparaginaseElsparAntineoplastic; lymphoid malignancies10,000 units per vial for injectionDog: 10,000 to 20,000 international units/m^2^ IV once weekly\
Cat: 400 units/kg SQ or IM (as part of a protocol)\
Pretreatment with antihistamine (diphenhydramine), 2 mg/kg (dog) and 1 mg/kg (cat) 30 minutes earlier is recommendedAspirinMany generic and brand name products (e.g., Bufferin, Ascriptin)NSAID; anticoagulant81- and 325-mg tabletsDog:\
Mild analgesia: 10-25 mg/kg q8-12h\
Antiinflammatory: 20-25 mg/kg q8-12h\
Antiplatelet: 5-10 mg/kg q24-48h\
To prevent thromboembolism (IMHA): 0.5 mg/kg/day\
Cat: 10-20 mg/kg q48h\
Antiplatelet: 80 mg q48hAtenololTenorminβ-blocker; hypertension and tachyarrhythmias25-, 50-, and 100-mg tablets;\
25 mg/mL oral suspension;\
and 0.5 mg/mL ampule\
for injectionDog: 6.25-12.5 mg/dog q12h\
(or 0.25-1.0 mg/kg q12-24h)\
Cat: 6.25-12.5 mg/cat q12h\
(approximately 3 mg/kg)§ AtipamezoleAntisedanTreatment of amitraz toxicity5.0 mg/mL, injection only50 mcg/kg IMAtracuriumTracriumNeuromuscular blocking\
agent; adjunct to general anesthesia for muscle relaxation10-mg/mL injection0.2 mg/kg IV initially; then 0.15 mg/kg q30min (or intravenous infusion at 3-8 mcg/kg/min)§ AtropineMany generic productsAntimuscarinic-anticholinergic; preanesthetic agent, treatment of some bradyarrhythmias400-, 500-, and 540 mcg/mL\
injection; 15 mg/mL injection0.02-0.04 mg/kg IV, IM, SQ q6-8h or 0.2-0.5 mg/kg (as needed) for organophosphate and carbamate toxicosisAuranofin (triethylphosphine gold)RidauraGold compound; immune-mediated skin disease3-mg capsule0.1-0.2 mg/kg PO q12hAurothioglucoseSolganalGold compound; immune-mediated skin disease50 mg/mL injectionDog \<10 kg: 1 mg IM 1st wk, 2 mg IM\
2nd wk, then 1 mg/kg/wk\
maintenance; \>10 kg: 5 mg IM 1st wk,\
10 mg 2nd wk, and then 1 mg/kg/wk maintenance\
Cat: 0.5-1 mg/cat IM q7daysAzathioprineImuranPurine antagonist; immunosuppressive agent50-mg tablet; 10 mg/mL injectionDog: 2 mg/kg PO q24h initially; then 0.5-1 mg/kg q48h\
Cat (use cautiously): 1 mg/kg PO q48h\
Monitoring patient CBC is indicated during therapy.AzithromycinZithromaxAntibacterial, broad-spectrum activity with extended half-life in tissue250-mg capsule; 250- and 600-mg tablets; 20 mg/mL oral suspensionDog: 5-10 mg/kg PO once daily for 3-5 days or 5 mg/kg PO once daily for 2 days, then every 3-5 days for a total of 5 doses\
Cat: 5-10 mg/kg PO daily for 3-5 daysBALSee *Dimercaprol*BenazeprilLotensinACE inhibitor; chronic heart failure, hypertension, first choice in treating protein-losing nephropathies5-, 10-, 20-, and 40-mg tabletsDog: Heart failure: 0.25-0.5 mg/kg PO q24h\
Hypertension: 0.25 mg/kg PO q12h\
Cat:\
Heart failure: 0.25-0.5 mg/kg PO once or twice daily\
Hypertension: 0.25-1.0 mg/kg PO once or twice dailyBetamethasoneCelestonePotent glucocorticoid and antiinflammatory; immune-mediated disease600-mcg (0.6-mg) tablet; 3 mg/mL sodium phosphate injectionDog and cat: Antiinflammatory: 0.1-0.2 mg/kg PO q12-24h\
Immunosuppressive: 0.2-0.5 mg/kg once or twice dailyBethanecholUrecholineMuscarinic-cholinergic; enhances urinary bladder contraction5-, 10-, 25-, and 50-mg tablets; 5 mg/mL injectionDog: 5-15 mg/dog PO q8h\
Cat: 1.25-5 mg/cat PO q8hBisacodylDulcolaxStimulant laxative5-mg tablet5 mg/animal PO q8-24hBismuth subsalicylatePepto-BismolGI protectant; treatment of simple (uncomplicated) diarrheaOral suspension; 262 mg/15 mL or 525 mg/mL in extra-strength formulation; 262-mg tablet0.25 mL/kg PO q4-6h up to 2mL/kg q6-8hBleomycinBlenoxaneAntineoplastic; used in multiple cancer protocols15-unit vials for injectionDog: 10 units/m^2^ IV or SQ once daily for 3 days; then 10 units/m^2^ weekly (maximum cumulative dose 200 units/m^2^)BromideSee *Potassium bromide*Bromocriptine mesylateParlodelDopamine agonist and prolactin inhibitor; pregnancy termination or pseudopregnancy (pseudocyesis) in dogs2.5-mg tablet and 5.0-mg capsulePseudocyesis: 10-100 mcg/kg PO once daily for 10 days, or 30 mcg/kg PO once daily for 16 days\
Pregnancy termination: 50-100 mcg/kg PO twice daily for 4-7 days; begin treatment from day 35-45 after LH surge\
*Caution:* Vomiting is a common side effect.BunamidineScolabanAntiparasitic; tape worms400-mg tablet20-50 mg/kg PO per treatmentBupivacaineMarcaine and genericLocal anesthetic (parenteral)2.5- and 5-mg/mL solution for injection1 mL of 0.5% solution/10 cm for an epiduralBuprenorphineBuprenexPartial opiate agonist analgesic0.3 mg/mL solutionDog: 0.005-0.02 mg/kg IV, IM, SQ q6-12h\
Cat: 0.005-0.01 mg/kg IV, IM q6-12h\
Buccal administration is well tolerated in cats, and effect lasts approximately 6 hours.Dog: 1mg/kg PO q8-12h (useful in social and panic disorders)BuspironeBusparNonbenzodiazepine anxiolytic; control of urine spraying5- and 10-mg tabletsCat: 2.5-5 mg/cat PO daily (may be increased to twice daily for some cats)BusulfanMyleranOral antineoplastic; chronic granulocytic leukemia2-mg tablet3-4 mg/m^2^ PO q24hButorphanolTorbutrol, TorbugesicOpioid analgesic; perioperative analgesia1-, 5-, and 10-mg tablets; 0.5 or 10 mg/mL injectionDog: Antitussive: 0.055 mg/kg SQ q6-12h or 0.55 mg/kg POPreanesthetic: 0.2-0.4 mg/kg IV, IM, SQ (with acepromazine) Analgesic: 0.2-0.4 mg/kg IV, IM, SQ q2-4h or 0.55-1.1 mg/kg PO q6-12h\
Cat: Analgesic: 0.2-0.8 mg/kg IV, SQ q2-6h or 1.5 mg/kg PO q4-8hCalcitriolRocaltrol, CalcijexCalcium supplement; increases calcium absorption in the GI tract; used in management of hypoparathyroidismAvailable as injection (Calcijex) and capsules (Rocaltrol): 0.25- and 0.5-mcg capsules; 1- or 2-mcg/mL injectionDog: 2.5-3.5 mg/kg PO once daily\
Cat: 1.65-3.63 mg/kg PO dailyCalcium carbonateGeneric and many brand name products (e.g., Tums)Calcium supplementMany tablets or oral suspension (e.g., 650-mg tablet contains 260 mg calcium ion)70-185 mg/kg/day PO in divided doses\
For phosphate binder: 60-100 mg/kg/day\
PO in divided doses§ Calcium chlorideGenericCalcium supplement (IV)10% (100 mg/mL) solution0.1-0.3 mL/kg IV (slowly)Calcium citrate (OTC)CitracalCalcium supplement950-mg tablet (contains 200 mg calcium ion)Dog: 20 mg/kg/day PO (with meals)\
Cat: 10-30 mg/kg q8h PO (with meals)§ Calcium gluconateKalcinate and genericCalcium supplement (IV)10% (100 mg/mL) injection0.5-1.5 mL/kg IV (slowly)Calcium lactate (OTC)GenericCalcium supplementAvailable as a powder and various-sized tabletsDog: 0.5-2.0 g/dog/day PO (in divided doses)\
Cat: 0.2-0.5 g/cat/day PO (in divided doses)CaptoprilCapotenACE inhibitor (vasodilator); hypertension and congestive heart failure25-mg tabletDog: 0.5-2 mg/kg PO q8-12h\
Cat: 3.12-6.25 mg/cat PO q8hCarbenicillinGeopen, PyopenAntibacterial1-, 2-, 5-, 10-, and 30-g vials for injectionNo longer available in the US\
Carbenicillin indanyl sodiumGeocillinAntibacterial500-mg tablet22-33 mg/kg PO q8h for 7-10 daysCarboplatinParaplatinAntineoplastic; multiple tumor types50- and 150-mg vials for injectionDog: 300 mg/m^2^ IV q3-4 wk\
Cat: 200 mg/m^2^ IV q4wk§ CarprofenRimadylNSAID25-, 75-, and 100-mg tablets\
50 mg/mL in 20-mL vials for injectionDog: 2.2 mg/kg PO or SQ q12h; or 4.4 mg/kg PO or SQ once daily\
Cat: Not approved for use in catsCascara sagrada (OTC)Many brand name productsLaxative100- and 325-mg tabletsDog: 1-5 mg/kg/day PO\
Cat: 1-2 mg/cat/dayCastor oil (OTC)GenericLaxativeOral liquid (100%)Dog: 8-30 mL/day PO\
Cat: 4-10 mL/day POCefaclorCeclorAntibacterial250- and 500-mg capsules and 25 mg/mL oral suspension7-13 mg/kg PO q8h for 14-21 days§ CefadroxilCefa-Tabs, Cefa-DropsAntibacterial50 mg/mL oral suspension; 50-, 100-, 200-, and 1000-mg tabletsDog: 22-30 mg/kg PO q12h\
Cat: 22 mg/kg PO q24hCefepimeMaxipimeAntibacterial500-mg, 1-g, and 2-g vials for injection40 mg/kg IV q6hCefiximeSupraxAntibacterial20 mg/mL oral suspension; 200- and 400-mg tablets10 mg/kg PO q12h\
For cystitis: 5 mg/kg PO q12-24hCefotaximeClaforanAntibacterial500-mg and 1-, 2-, and 10-g vials for injectionDog: 50 mg/kg IV, IM, SQ q12h\
Cat: 20-80 mg/kg IV, IM q6hCefotetanCefotanAntibacterial1-, 2-, and 10-g vials for injection30 mg/kg IV, SQ q8h§ CefoxitinMefoxinAntibacterial1-, 2-, and 10-g vials for injection30 mg/kg IV q6-8hCeftazidimeFortaz, Ceptaz, TazicefAntibacterial0.5-, 1-, 2-, and 6-g vials reconstituted to 280 mg/mLDog and cat: 30 mg/kg IV, IM q6h\
CRI: Loading dose 1.2 mg/kg; then 1.56 mg/kg/hr with IV fluidsCeftiofurNaxcel (ceftiofur sodium), Excenel (ceftiofur hydrochloride)Antibacterial50 mg/mL injectionDog: 30 mg/kg, SQ, q4-6h\
2.2-4.4 mg/kg SQ q24h (for urinary tract infections)§ CephalexinKeflex and genericAntibacterial, especially skin, urinary, respiratory tract infections250- and 500-mg capsules; 250- and 500-mg tablets; 100 mg/mL or 125 and 250 mg/5 mL oral suspension10-30 mg/kg PO q6-12h\
Pyoderma: 22-35 mg/kg PO q12hCephalothin sodiumKeflinAntibacterial1- and 2-g vials for injection10-30 mg/kg IV, IM q4-8hCephapirinCefadylAntibacterial500-mg and 1-, 2-, and 4-g vials for injection10-30 mg/kg IV, IM q4-8h§ Charcoal, activatedActa-Char, Charcodote, Toxiban, and genericGI adsorbentOral suspension1-4 g/kg PO (granules) 6-12 mg/kg (suspension)ChlorambucilLeukeranAntineoplastic; has also been used to treat eosinophilic granuloma complex in cats2-mg tabletDog: 2-6 mg/m^2^ q24h initially; then q48h PO\
Cat: 0.1-0.2 mg/kg q24h initially; then q48h POChloramphenicol and chloramphenicol palmitateChloromycetin and genericAntibacterial30 mg/mL oral suspension (palmitate); 250-mg capsule; and 100-, 250-, and 500-mg tabletsDog: 45-60 mg/kg PO q8h\
Cat: 25-50 mg/kg PO q12hChloramphenicol sodium succinateChloromycetin and genericAntibacterial100 mg/mL injectionDog: 40-50 mg/kg IV, IM q6-8h\
Cat: 12.5-20 mg/cat IV, IM q12hChlorothiazideDiurilDiuretic; also used as an antihypertensive250- and 500-mg tablets; 50 mg/mL oral suspension and injection20-40 mg/kg PO q12hChlorpheniramine maleate (OTC)Chlor-Trimeton, Phenetron, othersAntihistamine (H~1~-blocker), weak antipruritic agent in allergic animals4- and 8-mg tabletsDog: 4-8 mg/dog PO q12h (up to maximum of 0.5 mg/kg q12h)\
Cat: 2 mg/cat PO q12hChlorpromazineThorazineTranquilizer, antiemetic25-mg/mL injection solution0.5 mg/kg IM, SQ q6-8h\
Before cancer chemotherapy: 2 mg/kg SQ q3hChlortetracyclineGenericAntibacterialPowdered feed additive25 mg/kg PO q6-8hChorionic gonadotropinSee *Gonadotropin*CimetidineTagamet (available OTC and prescription)Antihistamine (H~2~ blocker); treatment and prevention of gastric ulcer100-, 150-, 200-, and 300-mg tablets; 60 mg/mL injection10 mg/kg IV, IM, PO q6-8h\
In renal failure: 2.5-5 mg/kg IV, PO q12hCiprofloxacinCipro (generic also available)Antibacterial250-, 500-, and 750-mg tablets, 2 mg/mL injection5-15 mg/kg PO, IV q12hCisapridePropulsidProkinetic; stimulates GI tract motility10-mg tabletDog: 0.1-0.5 mg/kg PO q8-12h (doses as high as 0.5-1.0 mg/kg have been used in some dogs)\
Cat: 2.5-5 mg/cat PO q8-12h (doses as high as 1 mg/kg q8h have been used in cats)CisplatinPlatinolAntineoplastic; multiple tumor types1-mg/mL injection; 50-mg vialDog: 60-70 mg/m^2^ IV over 20 minutes after a 4-hour IV saline diuresis, continue diuresis after cisplatin infusion for 2 more hours (repeat every 3-4 weeks)\
Cat: *Do not use*ClemastineTavist, Contac 12 Hour, and genericAntihistamine (H~1~-blocker), antipruritic in allergic dogs1.34-mg tablet (OTC); 2.64-mg tablet (prescription); 0.134 mg/mL syrupDog: 0.05-0.1 mg/kg PO q12h§ ClindamycinAntirobe, CleocinAntibacterial, especially gram-positive infections; recommended for toxoplasmosis (controversial)25 mg/mL oral liquid; 25-, 75-, and 150-mg capsules; and 150-mg/mL injection (Cleocin)Dog: 11 mg/kg PO q12h or 22 mg/kg PO q24h\
Cat: 5.5 mg/kg q12h, or 11 mg/kg q24h (staphylococcal infections); 11 mg/kg q12h or 22 mg/kg q24h (anaerobic infections) PO\
Toxoplasmosis: 12.5 mg/kg PO q12h for 4 wkClofazimineLampreneAntibacterial50- and 100-mg capsulesCat: 1 mg/kg PO up to maximum of 4 mg/kg/dayClomipramineAnafranil (human);\
Clomicalm (veterinary)Tricyclic antidepressant; behavior modification10-, 25-, and 50-mg tablets (human); 5-, 20-, and 80-mg tablets (veterinary)Dog: 2-4 mg/kg PO once daily or divided twice daily\
Cat: 0.5-1 mg/kg PO once dailyClonazepamKlonopinAnticonvulsant; also used to manage certain types of behavior disorders0.5-, 1-, and 2-mg tablets0.5 mg/kg PO q8-12hClorazepateTranxeneAnticonvulsant; also used to manage certain types of behavior disorders3.75-, 7.5-, 11.25-, 15-, and 22.5-mg tablets2 mg/kg PO q12hClotrimazoleMany generic products, including lotrimazole topical solution, USP 1%Antifungal (topical only); nasal aspergillosis1% topical solution in 30 mLFor nasal aspergillosis in dogs: Infuse 1% solution in each nasal cavity for 1 h in anesthetized dog. *Note:* Patient preparation is required.CloxacillinCloxapen, Orbenin, TegopenAntibacterial250- and 500-mg capsules; 25 mg/mL oral solution20-40 mg/kg PO q8hCodeineGenericOpioid analgesic15-, 30-, and 60-mg tablets; 5 mg/mL syrup; 3 mg/mL oral solutionAnalgesia: 0.5-2 mg/kg PO q6-8h\
Antitussive: 0.1-0.3 mg/kg PO q6-8hColchicineGenericAntiinflammatory; hepatic failure500- and 600-mcg tablets; 500 mcg/mL ampule injection0.01-0.03 mg/kg PO q24hColony-stimulating factorFilgrastimHormone; stimulates granulocyte production in bone marrow300 mcg/mL injection5mcg/kg SQ q24h for 5 days at a time (pulse therapy)§ Corticotropin (ACTH gel)H.P. Acthar Gel (expensive)Hormone; diagnostic test drug for the diagnosis of hyperadrenocorticism and hypoadrenocorticism5 mL (multiple dose) 80 USP units/mLResponse test: Collect pre-ACTH sample and inject 2.2 international units/kg IM;\
Dog: Collect post-ACTH sample in 2 hr\
Cat: Collect post-ACTH samples at 1 and 2 hr§ CosyntropinCortrosynHormone; diagnostic test drug for the diagnosis of hyperadrenocorticism and hypoadrenocorticism250 mcg per vial (can be stored in freezer for 6 months)Response test: Dog: Collect presample and inject 5 mcg/kg IV\
Cat: Collect presample and inject 0.125 mg IV\
Dog and cat: Collect postsample 1 hr postadministrationCyanocobalaminSee *Vitamin B*~12~CyclophosphamideCytoxan, NeosarAntineoplastic; multiple tumor types, and adjunctive in immune-mediated disorders25 mg/mL injection; 25- and 50-mg tabletsAnticancer: 50 mg/m^2^ PO once daily 4 days/wk or 150-300 mg/m^2^ IV and repeat in 21 days\
Immunosuppressive therapy: 50 mg/m^2^ (approx 2.2 mg/kg) PO q48h or 2.2 mg/kg once daily for 4 days/wk\
Cat: 6.25-12.5 mg/cat once daily 4 days/wkCyclosporine (cyclosporin A)Neoral, Sandimmune, Optimmune (ophthalmic)Immunosuppressant (CMI); multiple uses ranging from atopic dermatitis to hemolytic anemia to perianal fistulas. Consult additional references before prescribingNeoral: 25-mg and 100-mg microemulsion capsules; 100-mg/mL oral solution (for microemulsion)\
Sandimmune: 100-mg/mL oral solution; 25- and 100-mg capsules\
Optimmune: 0.2% ointmentDog: 3-7 mg/kg PO q12-24h (adjust dose based on condition being treated and by monitoring blood levels)\
Hemolytic anemia: Up to 10 mg/kg PO q12h (as adjunctive therapy)\
Cat: 4-6 mg/kg PO q12h\
*Note:* Multiple products are available but all are *not* bioequivalent.CyproheptadinePeriactinAntihistamine; appetite stimulant in cats4-mg tablet; 2 mg/5 mL syrupAntihistamine: 1.1 mg/kg PO q8-12h\
Appetite stimulant: 2 mg/cat POCytarabine (cytosine arabinoside)Cytosar-UAntineoplastic; lymphoma and leukemia100-mg vialDog (lymphoma): 100 mg/m2 IV, SQ once daily or twice daily for 4 days\
Cat: 100 mg/m^2^ once daily for 2 daysDacarbazineDTICAntineoplastic; lymphoreticular neoplasms and soft tissue sarcomas200-mg vial for injection200 mg/m^2^ IV for 5 days q3wk; or 800-1000 mg/m^2^ IV q3wk§ DalteparinFragminLow--molecular-weight heparin; management of thromboembolic diseaseMultiple injectable preparationsProphylaxis: 70 units/kg SQ q24h\
Treatment:\
Dog: 100-150 units/kg SQ q24h\
Cat: 180 units/kg SQ q24hDanazolDanocrineAnabolic steroid; adjunctive therapy for immune-mediated disease50-, 100-, and 200-mg capsules5-10 mg/kg PO q12hDantroleneDantriumMuscle relaxant; urethral obstruction, and prevention of malignant hyperthermia100-mg capsules; 0.33 mg/mL injectionMalignant hyperthermia: 2-3 mg/kg IV\
Muscle relaxation:\
Dog: 1-5 mg/kg PO q8h\
Cat: 0.5-2 mg/kg PO q12hDapsoneGenericAntibacterial;\
*Mycobacterium* species25- and 100-mg tablets1.1 mg/kg PO q8-12h§ DeferoxamineDesferalAntidote, iron toxicosis500-mg vial for injection10 mg/kg IV, IM q2h for two doses; then 10 mg/kg q8h for 24 hrDeprenyl ([l]{.smallcaps}-deprenyl)See *Selegiline*§ Desmopressin acetateDDAVPHormone; used in the clinical management of patients with DI and patients with von\
Willebrand disease100 mcg/mL injection and desmopressin acetate nasal solution (0.01% metered spray); 0.1- and 0.2-mg tabletsDI: 1-4 drops q12-24h in the conjunctival sac or 2-5 mcg SQ q12-24h animal oral dose not established, but dose extrapolated from humans is 0.05 mg/animal q12h PO with increase to 0.1 or 0.2 mg/animal as needed von Willebrand disease: 1 mcg/kg SQ, IV diluted in 20 mL saline administered over 10 minDesoxycorticosterone pivalatePercorten-V, DOCP, DOCA pivalateMineralocorticoid; hypoadrenocorticism25 mg/mL suspension for injection1.5-2.2 mg/kg IM q25daysDexamethasone (dexamethasone solution and dexamethasone sodium phosphate)Azium solution in polyethylene glycol; sodium phosphate forms include DexaJect SP, Dexavet, and Dexasone; tablets include Decadron and genericGlucocorticoid; multiple uses as antiinflammatory and immunosuppressive agent; also used in the diagnosis of hyperadrenocorticismAzium solution, 2 mg/mL; sodium phosphate forms are 3.33 mg/mL; 0.25-, 0.5-, 1-, 1.5-, 2-, 4-, and 6-mg tablets.Antiinflammatory: Dog: 0.5-1 mg IV or IM q24h for 3-5 days or 0.25-1.25 mg PO q24h\
Cat: 0.125-0.5 mg IV or IM for 3-5 days or 0.125-0.5 mg PO q24h\
For shock, spinal injury: 2.2-4.4 mg/kg IV (of sodium phosphate form) For diagnostic testing: See Dexamethasone Suppression Test in Section 5DextromethorphanBenylin and othersAntitussive, weak cough suppressantAvailable in syrup, capsule, and tablet; many OTC products0.5-2 mg/kg PO q6-8h§ Dextrose solution 5% in waterD5WReplacement fluidFluid solution for IV administration40-50 mL/kg IV q24h§ DiazepamValium and genericAnticonvulsant; multiple neurotropic effects ranging from behavior disorders to seizure control2- and 5-mg tablets; 5 mg/mL solution for injectionPreanesthetic: 0.1 mg/kg IV slowly\
Status epilepticus: 0.5 mg/kg IV, 1.0 mg/kg rectal; repeat if necessary\
Appetite stimulant (cat): 0.05-0.4 mg/kg IV, IM or PO§ DichlorphenamideDaranideDiuretic; management of glaucoma50-mg tablet3-5 mg/kg PO q8-12hDichlorvosTaskAntiparasitic; roundworms, hookworms, whipworms10- and 25-mg tabletsDog: 26.4-33 mg/kg PO\
Cat: 11 mg/kg PODicloxacillinDynapenAntibacterial125-, 250-, and 500-mg capsules; 12.5 mg/mL oral suspension25 mg/kg PO q6h\
Oral doses not absorbedDiethylcarbamazine (DEC)Caricide, FilaribitsAntiparasitic; prevention of heartworm disease in dogs; treatment of ascarids in catsChewable tablets; 50-, 60-, 180-, 200-, and 400-mg tabletsHeartworm prophylaxis: 6.6 mg/kg PO q24h\
Cat (for ascarids): 55-110 mg/kg PO onceDiethylstilbestrol (DES)Limited availability; compounding requiredHormone; estrogen replacement and urinary incontinence; induces abortion in dogsTablets (prepared through compounding pharmacies)Dog: 0.1-1.0 mg/dog PO q24h for 5 days, then 1 mg PO once weekly\
Cat: 0.1-1 mg/cat PO q24h for 5 days, then 1 mg PO once weeklyDifloxacinDicuralAntibacterial11.4-, 45.4-, and 136-mg tablets5-10 mg/kg/day PODigitoxinCrystodiginCardiac inotrope; congestive heart failure and management of various tachyarrhythmias0.05- and 0.1-mg tablets0.02-0.03 mg/kg PO q8hDigoxinLanoxin, CardoxinCardiac inotrope; congestive heart failure and management of various tachyarrhythmias0.0625-, 0.125-, 0.25-mg tablets; 0.05 and 0.15 mg/mL elixirDog: \<20 kg, 0.01 mg/kg q12h; \>20 kg, 0.22 mg/m^2^ PO q12h (subtract 10% for elixir)\
Dog (rapid digitalization): 0.0055-0.011 mg/kg\
IV q1h to effect\
Cat: 0.008-0.01 mg/kg PO q48h (approximately ¼ of a 0.125-mg tablet/cat)Dihydrotachysterol (DHT)See *Vitamin D analogue*§ DiltiazemCardizem, DilacorCalcium channel blocker; hypertension; also supraventricular tachycardia and hypertrophic cardiomyopathy30-, 60-, 90-, and 120-mg tablets; 50 mg/mL injectionDog: 0.5-1.5 mg/kg PO q8h; 0.25 mg/kg over 2 min IV (repeat if necessary)\
Cat: 1.75-2.4 mg/kg PO q8h; for Dilacor XR or Cardizem CD, dose is 10 mg/kg PO once daily§ DimenhydrinateDramamineAntihistamine; prevention of motion sickness50-mg tablets; 50 mg/mL injectionDog: 4-8 mg/kg PO, IM, IV q8h\
Cat: 12.5 mg/cat IV, IM, PO q8hDimercaprol (BAL)BAL in oilChelating agent; binds heavy metals (lead, mercury) and arsenicals100 mg/mL injection2.5-5 mg/kg IM q4h for 2 days, then q8h for 1 day, then q12h for next 10 daysDinoprost tromethamineSee *Prostaglandin F2-alpha*Dioctyl calcium sulfosuccinateSee *Docusate calcium*Dioctyl sodium sulfosuccinateSee *Docusate sodium*§ DiphenhydramineBenadrylAntihistamine; weak sedative, prevents motion sicknessAvailable OTC: 2.5 mg/mL elixir; 25- and 50-mg capsules and tablets; 50 mg/mL injection2-4 mg/kg PO q6-8h or 1 mg/kg IM, IV (for dogs, administer 25-50 mg/dog IV, IM, PO q8h)DiphenoxylateLomotilMeperidine congener; treatment of diarrhea2.5-mg tabletDog: 0.1-0.2 mg/kg PO q8-12h\
DiphenylhydantoinSee *Phenytoin*Diphosphonate disodium etidronateSee *Etidronate disodium*DipyridamolePersantineAnticoagulant; prevention of thromboembolism25-, 50-, 75-mg tablets; 5 mg/mL injection4-10 mg/kg PO q24hDisopyramideNorpaceAntiarrhythmic in dogs; oral treatment or prevention of ventricular arrhythmias (dog only)100- and 150-mg capsulesDog: 11-22 mg/kg, PO, q8hDivalproex sodiumSee *Valproic acid*§ DobutamineDobutrexRapid acting cardiac inotrope (β-agonist); short-term treatment of heart failure250 mg/20 mL vial for injection (12.5 mg/mL)Dog: 5-20 mcg/kg/min intravenous infusion\
Cat: 0.5-2 mcg/kg/min intravenous infusion\
*Warning:* may induce arrhythmias, facial twitching, or seizure (cats)Docusate calciumSurfak, DoxidanStool softener60-mg tablet (and many others)Dog: 50-100 mg/dog PO q12-24h\
Cat: 50 mg/cat PO q12-24hDocusate sodiumColace, Doxan, Doss, many OTC productsStool softener50- and 100-mg capsules; 10 mg/mL liquidDog: 50-200 mg/dog PO q8-12h\
Cat: 50 mg/cat PO q12-24h§ DolasetronAnzemet5-HT~3~ receptor antagonist, antiemetic50- and 100-mg tablets; 20 mg/mL injectionPrevention: 0.6 mg/kg PO or IV q24h\
Treatment: 1 mg/kg PO or IV q24h[l]{.smallcaps}-DopaSee *Levodopa*§ DopamineIntropinCardiac inotrope (β-agonist); vasodilation (lower doses); adjunctive treatment of acute heart failure and oliguric renal failure40-, 80-, or 160-mg/mL injection2-10 mcg/kg/min by intravenous infusion; treatment limited to the critical care setting§ DoxapramDopramCNS stimulant; stimulates respiration, especially in neonates20-mg/mL injection5-10 mg/kg IV\
Neonate: 1-5 mg SQ, sublingually, or via umbilical veinDoxepinSinequanTricyclic antidepressant; psychogenic dermatosesVarious capsules; 10 mg/mL oral solutionDog: 3-5 mg/kg PO q12h (especially lick granuloma)Cat: 0.5-1 mg/kg PO q12hDoxorubicinAdriamycinAntineoplastic (antibiotic); used in treatment protocols for multiple tumor types2 mg/mL injection30 mg/m^2^ IV q21days; or \>20 kg, 30 mg/m^2^; \<20 kg, 1 mg/kg\
Cat: 1 mg/kg IV q3wkDoxycyclineVibramycin and genericAntibacterial10 mg/mL oral suspension; 100-mg tablet; 100-mg injection vial3-5 mg/kg PO, IV q12h; or 10 mg/kg PO q24h\
For *Rickettsia* in dogs: 5 mg/kg q12hEdrophoniumTensilon, othersShort-acting cholinergic; administered as a test agent for myasthenia gravis10 mg/mL injectionDog: 0.11-0.22 mg/kg IV\
Cat: 0.25-0.5 mg/cat IV§ EDTA (edetate calcium disodium)Calcium disodium versenateChelates heavy metals; treatment of lead or zinc toxicosis20 mg/mL injection25 mg/kg SQ, IM, IV q6h for 2-5 daysEnalaprilEnacardACE inhibitor; vasodilator used in the treatment of heart failure and/or hypertension; also used in the treatment of patients with protein-losing nephropathies and chronic renal failure2.5-, 5-, 10-, and 20-mg tabletsDog: 0.5 mg/kg PO q12-24h\
Cat: 0.25-0.5 mg/kg PO q12-24hEnfluraneEthaneInhalation anestheticAvailable as solution for inhalationInduction: 2%-3%\
Maintenance: 1.5%-3%EnilconazoleImaverol, Clinafarm-ECAntifungal (topical only); infusion for treatment of nasal aspergillosis and topical uses in certain dermatophytoses10% or 13.8% emulsifiable concentrateNasal aspergillosis: 10 mg/kg q12h instilled into nasal sinus via surgically implanted tubes for 14 days (10% solution diluted 50/50 with water)---this is nasty!\
*Note:* Generally replaced by clotrimazole soak (see *Clotrimazole*)\
Dermatophytes: Dilute 10% solution to 0.2% and wash lesion with solution four times at 3- to 4-day intervals§ EnoxaparinLovenoxLow--molecular-weight heparin; thromboembolic diseaseMultiple preparationsDog: 0.8 mg/kg SQ q12hCat: 0.5-1 mg/kg SQ q6h\
§ EnrofloxacinBaytrilAntibacterial68-, 22.7-mg, and 5.7-mg tablets; Taste Tabs are 22.7 and 68 mg; 22.7 mg/mL injectionDog: 5-20 mg/kg PO or IM once daily or divided twice daily\
Cat: 2.5-5 mg/kg PO, SQ, IM once to twice daily\
Parenteral solution for intramuscular use has been administered by the intravenous route---administer slowly if indicated.\
*Warning:* Doses of 10 mg/kg and higher are not recommended in cats because of risk of drug-induced retinal damage and blindness.§ EphedrineEphedrine sulfateSympathomimetic; primarily for urinary incontinence\
*Emergency use:* Hypotension associated with anesthesia25-mg capsules and 50 mg/mL in 1-mL ampules for injectionUrinary incontinence:\
Dog: 4 mg/kg, or 12.5-50 mg/dog (total) PO q8-12h; Also, 1-2 mg/kg PO q8h, or 5 to 15 mg/dog (total) q8h\
Cat: 2-4 mg/kg, PO q8-12h\
Hypotension: 0.03-0.1 mg/kg intravenous bolus\
*Note:* Dilute 5 mg in 10 mL saline; give the lower dose first; may repeat in 5 minutes after first dose if hypotension does not improve.§ EpinephrineAdrenalin and generic products (adrenaline)α- and β-Adrenergic agonist; anaphylaxis and cardiac arrest1 mg/mL (1:1,000) injection solutionCardiac arrest: 10-20 mcg/kg IV or 200 mcg/kg intratracheal (may be diluted in saline)\
Anaphylaxis: 2.5-5 mcg/kg IV or 50 mcg/kg intratracheal (may be diluted in saline)EpsiprantelCestexOral cesticide; tapewormsCoated tabletDog: 5.5 mg/kg PO given once\
Cat: 2.75 mg/kg PO given onceErgocalciferolSee *Vitamin D*~2~ErythromycinMany brand name and generic productsAntibacterial; also used as a prokinetic (increases gastric emptying in dogs and cats)250-mg capsule or tabletAntibacterial dose: 10-20 mg/kg PO q8-12h\
Prokinetic dose: 0.5-1.0 mg/kg PO q8hErythropoietin, human recombinant (rHuEPO); also, EPOEpogen, Eprex, ProcritHormone; induction of erythropoiesis in anemia associated with chronic renal failureVarious preparation as units per milliliter in single-dose and multidose vials for injectionDoses range from 35 or 50 units/kg three times per week to 400 units/kg/wk IV, SQ (adjust dose to hematocrit of 0.30-0.34)§ EsmololBreviblocUltra-short-acting β~1~ blocker; short-term treatment of cardiac arrhythmias, especially supraventricular tachycardia10 mg/mL injection500 mcg/kg IV, which may be given as 0.05-0.1 mg/kg slowly every 5 minutes or 50-200 mcg/kg/min infusionEstradiol cypionate (ECP)DEPO-Estradiol, genericHormone; previously used to prevent pregnancy after an unplanned breeding *Warning: Not* recommended for use as an abortifacient in dogs or cats2 mg/mL injectionPregnancy avoidance:\
Dog: 22-44 mcg/kg IM (total dose not to exceed 1.0 mg)\
Cat: 250 mcg/cat IM between 40 hr and 5 days of mating\
*Warning:* May cause bone marrow suppression; in some cases, may cause aplastic anemiaEtidronateDidronelBisphosphonate; reduced calcium resorption from bone in hypercalcemic patients200- and 400-mg tablets; 50 mg/mL injectionDog: 5 mg/kg/day PO\
Cat: 10 mg/kg/day POEtodolacEtoGesicOral NSAID; pain management in dogs150- and 300-mg tabletsDog: 10-15 mg/kg PO once daily\
Cat: *Do not use*§ FamotidinePepcidH~2~-receptor antagonist; reduces gastric acid production, used to treat or prevent gastric ulcer10-mg tablet; 10 mg/mL injection0.5 mg/kg IM, SQ, IV, or PO q12-24h\
*Warning:* May cause intravascular hemolysis when given IV to catsFelbamateFelbatolDicarbamate anticonvulsant; management of seizures in dog only400- and 600-mg tablets; 120 mg/mL flavored oral suspensionDog: Start with 15 mg/kg PO q8h and increase gradually to maximum of 65 mg/kg q8hFenbendazoleSafe-Guard, PanacurAnthelmintic; effective against a variety of internal parasitesPanacur granules 22.2% (222 mg/kg); 100 mg/mL liquid25 to 50 mg/kg/day PO for 3 days (*Note:* For some parasites, recommended treatment duration may be longer.)FentanylSublimaze, genericAnalgesic (opiate); parenteral pain control250 mg/5 mL injection0.02-0.04 mg/kg IV, IM, SQ q2h; or 0.01 mg/kg IV, IM, SQ (with acetylpromazine or diazepam)\
For analgesia: 0.01 mg/kg IV, IM, SQ q2hFentanyl transdermalDuragesicAnalgesic (opiate); transdermal pain control25-, 50-, 75-, and 100-mcg/hr patchesDog: 10-20 kg, 50 mcg/hr patch q72h\
Cat: 25 mcg/hr patch every 3 days\
*Note:* When fentanyl is administered by the transdermal route, dosage regimens can vary among patients; consult individual sources to match patient size with patch size and patch placement. Do not cut the patch to achieve lower doses.Ferrous sulfate (OTC)GenericOral iron supplement; iron deficiency anemiaMany oral preparations availableDog: 100-300 mg/dog PO q24h\
Cat: 50-100 mg/cat PO q24hFinasterideProscar5α-reductase inhibitor; benign prostatic hyperplasia in dogs5-mg tabletDog: 0.1 mg/kg PO q24h or 5 mg/10- to 50-kg dog PO q24hFipronilFrontlineGABA-regulated chloride channel inhibitor; topical control of ticks and fleasTopical solution onlyApplied topically once each month as recommended by the manufacturer; approved for use in both dogs and catsFirocoxibPrevicoxNSAID; management of inflammation and pain associated with osteoarthritis in dogs57-mg and 227-mg chewable tabletsDogs: 5 mg/kg, PO, once daily\
Cats: 1.5 mg/kg administered as a single dose\
Long-term safety has not been established in cats.FlorfenicolNuflorAntibacterial (primarily used in cattle)300 mg/mL (available only as a cattle preparation)Dog: 25-50 mg/kg q8h SQ or IM\
Cat: 25-50 mg/kg q12h SQ or IMFluconazoleDiflucanAntifungal, oral (dog and cat) or parenteral (dog only); treatment for systemic deep mycoses or nasal fungal infection50-, 100-, 150-, and 200-mg tablets; 10 or 40 mg/mL oral suspension; 2 mg/mL intravenous injectionDog: 2.5-5.0 mg/kg once daily PO or IV\
Cat: 2.5-10 mg/cat PO q12h; or 25 mg/cat/day POFlucytosineAncobonAntifungal; treatment of systemic mycoses250-mg capsule; 75 mg/mL oral suspension25-50 mg/kg PO q6-8h (up to a maximum dose of 100 mg/kg PO q12h)FludrocortisoneFlorinefMineralocorticoid; treatment of hypoadrenocorticism100-mcg (0.1-mg) tabletDog: 0.2-0.8 mg/dog or 0.02 mg/kg PO q24h (13-23 mcg/kg)\
Cat: 0.1-0.2 mg/cat PO q24h§ FlumazenilRomaziconBenzodiazepine antagonist; antidote to reverse therapeutic effects or overdose100 mcg/mL (0.1 mg/mL) injection0.01-0.02 mg (total dose) IV as needed\
*Caution:* May cause significant hypotensionFlumethasoneFlucortOral glucocorticoid; antiinflammatory0.5 mg/mL injectionDog: 0.0625-0.25 mg/day in divided doses IV, IM, SQ\
Cat: 0.03-0.125 mg/day IV, IM, SQFlunixin meglumineBanamineNSAID; pain management250-mg packet granules; 10 and 50 mg/mL injection\
PO 3 days/wk\
Ophthalmic: 0.5 mg/kg IV once5-Fluorouracil (5-FU)FluorouracilAntineoplastic; used in treatment protocols for multiple tumor types50-mg/mL vialDog: 150 mg/m^2^ IV once/week\
Cat: *Do not use*FluoxetineProzacSSRI; treatment of behavior disorders10- and 20-mg capsules; 4 mg/mL oral solutionDog: 0.5 mg/kg day initially PO; then increase to 1 mg/kg/day PO (10-20 mg/dog)\
Cat: 0.5-4 mg/cat PO q24hFluvoxamineLuvoxSSRI; treatment and diagnosis of behavior disorders25-, 50-, and 100-mg tablesDog: 0.5-2.0 mg/kg, PO, bid\
Cat: 0.25-0.5 mg/kg PO once daily§ Fomepizole (4-methylpyrazole; 4-MP)Antizol-VetAntidote; ethylene glycol poisoning1.5-mL single-use vial; reconstitute in 30 mL of 0.9%\
NaCl for a 5% solution (50 mg/mL)20 mg/kg IV initially within 8 hr of ingestion; then 15 mg/kg IV at 12- and 24-hr intervals; then 5 mg/kg IV at 36 hr\
*Note:* Cats require 7 × the dose used in dogs; agent is effective only if administered within 3 hr after ingestion of ethylene glycol.FurazolidoneFuroxoneAntibacterial and antiprotozoal; generally a second-choice drug100-mg tablet4 mg/kg PO q12h for 7-10 days§ FurosemideLasix, genericDiuretic; multiple uses; commonly used to treat congestive heart failure and pulmonary edema12.5-, 20-, and 50-mg tablets; 10 mg/mL oral solution; 50 mg/mL injectionDog: 2-6 mg/kg IV, IM, SQ, PO q8-12h (or as needed); 0.6-1.0 mg/kg/h IV\
Cat: 1-4 mg/kg IV, IM, SQ, PO q8-24hGemfibrozilLopidAntilipemic; treatment of hypertriglyceridemia in patients that do not respond to dietary fat restriction300-mg capsule; 600-mg tablet7.5 mg/kg PO q12hGentamicinGentocinAntibacterial (aminoglycoside)50 and 100 mg/mL solution for injectionDog: 2-4 mg/kg q6-8h or 6-10 mg/kg IV,\
IM, SQ q24h\
Cat: 3 mg/kg q8h or 9 mg/kg IV, IM,\
SQ q24h\
*Warning:* Do *not* administer to patients that are dehydrated or acidotic; can cause acute renal failure.GlipizideGlucotrolOral hypoglycemic; variably effective control of type 2 diabetes in cats5- and 10-mg tablets2.5-7.5 mg/cat PO q12h; usual dose is 2.5 mg/cat initially; then increase to 5 mg/cat q12h§ GlucagonGlucagon Emergency Kit (Lilly), GlucaGen (products are rDNA origin)Parenteral hyperglycemic; treatment of acute hypoglycemia and/or insulin overdose1 mg (1.0 unit) per vialDilute 1 mg glucagon in 1 L of 0.9% sterile saline. Resulting concentration: 1000 mg/mL\
Administer 50 mg/kg (or 0.05 mL/kg of diluted solution) by intravenous bolus, then 10 to 15 mg/kg/min IV by CRI as needed to correct hypoglycemia.Glucosamine + chondroitin sulfateCosequin and other brandsNeutraceutical; adjunctive treatment of nonseptic arthritis; may be useful in treating cats with lower urinary tract disease (FLUTD)Regular-strength (RS) and double-strength (DS) capsulesDog: 1 or 2 RS capsules per day (2-4 capsules of DS for large dogs)\
Cat: 1 RS capsule dailyGlyburideDiabeta, Micronase, GlynaseOral hypoglycemic; variably effective control of type 2 diabetes in cats1.25-, 2.5-, and 5-mg tablets0.625 mg per cat once daily (represents one half of 1.25-mg tablet)Glycerin (OTC)GenericOral osmotic; reduces intraocular (and CSF) pressureOral solution1-2 mL/kg PO q8hGlycopyrrolateRobinul-VAntimuscarinic; multiple uses---preanesthetic medication, antidote0.2 mg/mL injection0.005-0.011 mg/kg IV, IM, SQGold sodium thiomalateMyochrysineGold salt; treatment of immune-mediated skin disordersInjection1-5 mg IM first wk, then 2-10 mg IM second wk, then 1 mg/kg IM once/wk maintenanceGold therapySee *Aurothioglucose*GoLYTELYSee *Polyethylene glycol electrolyte solution*Gonadorelin (GnRH, LHRH)FactrelHormone; diagnosis and treatment of various reproductive disorders50 mcg/mL injectionTherapeutic doses:\
Dog: 50-100 mcg/dog SQ, IV, IM q24-48h × 2 doses\
Cat: 25 mcg/cat IM onceGonadotropin, human chorionic (hCG)Profasi, Pregnyl, APL, and genericHormone; induces luteinization5000-, 10,000-, and 20,000-unit injectionDog: 22 units/kg IM q24-48h or 44 units IM once\
Cat: 250 units/cat IM once\
*Warning:* Do *not* use in pregnant animals.Gonadotropin-releasing hormoneSee *Gonadorelin*GranisetronKytrilAntiemetic; prevents emesis associated with chemotherapy1 mg/mL injection; 1-mg tablet0.01 mg/kg (10 mcg/kg) IVGriseofulvin (microsize)Fulvicin U/FAntifungal (fungistatic antibiotic); treatment of dermatophytes (especially *Microsporum canis*)125-, 250-, and 500-mg tablets; 25 mg/mL oral suspension; 125 mg/mL oral syrup50 mg/kg PO q24h (up to a maximum dose of 110-132 mg/kg/day in divided treatments)Growth hormone (hGH)Humatrope, Nutropin, Protropin, Somatotropin, SomatremHormone; replacement hormone in patients with confirmed deficiency5- and 10-mg vials0.1 unit/kg SQ, IM three times per week for 4-6 wk *Warning:* Is diabetogenicHalothaneFluothaneInhalation anesthetic250-mL liquidInduction: 3%\
Maintenance: 0.5%-1.5%§ Heparin sodiumLiquaeminAnticoagulant; treatment of DIC, treatment and prevention of thromboembolic disease1000 and 10,000 units/mL injection100-200 units/kg IV loading dose, then 100-300 units/kg SQ q6-8h\
Low-dose prophylaxis (dog and cat): 70 units/kg SQ q8-12h§ HydralazineApresolineVasodilator; hypertension and adjunctive treatment of heart failure10-mg tablet; 20 mg/mL injectionDog: 0.5 mg/kg (initial dose); titrate to 0.5-2 mg/kg PO q12h\
Cat: 2.5 mg/cat PO q12-24hHydrochlorothiazideHydroDIURIL, genericDiuretic; hypertension, congestive heart failure, and nephrogenic (ADH-resistant) DI10 and 100 mg/mL oral solution; 25-, 50-, and 100-mg tablets2-4 mg/kg PO q12h§ Hydrocodone bitartrateHycodan (contains atropine)Analgesic (opiate); pain management5-mg tabletDog: 0.22 mg/kg PO q4-8h\
Cat: no dose availableHydrocortisoneCortef and genericGlucocorticoid; antiinflammatory and replacement therapy in adrenal insufficient conditions5-, 10-, and 20-mg tabletsReplacement therapy: 0.2-0.5 mg/kg PO q24h\
Antiinflammatory: 1.5-5 mg/kg PO q12h§ Hydrocortisone sodium succinateSolu-Cortef and shock treatmentGlucocorticoid; antiinflammatory injectionVarious size vials for antiinflammatory: 5 mg/kg IV q12hShock: 50-150 mg/kg IV§ HydromorphoneDilaudidAnalgesic (opiate); pain management and restraintTablets, oral solution, and injectable forms availableDog: 0.22 mg/kg, IM, SQ, q4-6h as needed for pain§ Hetastarch, Hydroxyethyl starch (HES)Hespan, HextendVolume expander; used when colloidal therapy is indicatedInjection10-20 mL/kg IV to effect, 20-30 mL/kg/dayHydroxyureaHydreaAntineoplastic; polycythemia vera, mastocytoma, leukemias500-mg capsuleDog: 50 mg/kg PO once daily, 3 days/wk\
Cat: 25 mg/kg PO once daily, 3 days/wkHydroxyzineAtaraxAntihistamine; antipruritic and sedative effects, especially in atopic patients10-, 25-, and 50-mg tablets; 2 mg/mL oral solutionDog: 1-2 mg/kg q6-8h IM, PO\
Cat: 5-10 mg/cat PO q8-12hIfosfamideIfexAntineoplastic; lymphomas and other sarcomas1 g powder for intravenous infusion in single-dose vialsDogs and cats: Dose ranges from 300 to 500 mg/m^2^ IV\
*Caution:* Consult treatment protocol before administering.ImidaclopridAdvantageTopical flea treatment for dogs and catsTopical solutionApply topically once monthly as directed by the manufacturer for the treatment of fleas.Imidacloprid + permethrinK9 AdvantixTopical flea treatment and tick repellent for *dogs only*Topical solutionApply topically once monthly as directed by the manufacturer for the treatment of fleas.\
Cat: *Do not use;* contains permethrin.Imidocarb dipropionateImizolAntiprotozoal; treatment of babesiosis, ehrlichiosis (not regarded as effective), *Cytauxzoon felis,* and related infectionsParenteral solution for injection IM or SQ; 120 mg/mL in 10-mL multidose vialDog: 5 mg/kg IM or SQ once; repeat in 2 wk\
For babesiosis: 6.6 mg/kg IM or SQ once; repeat in 2 wk\
Cat: (cytauxzoonosis) 5 mg/kg IM q2wk as neededImipenem + cilastatinPrimaxinAntibacterial250- and 500-mg vials for injection5-10 mg/kg IV, IM q6-8h; has been administered to dogs at 10 mg/kg q8h SQImipramineTofranilTricyclic antidepressant; treatment of behavior disorders10-, 25-, and 50-mg tablets2-4 mg/kg PO q12-24hIndomethacinIndocinSafe dose has not been established.Interferon (interferon alfa-2a, HuIFN-alpha)RoferonCytokine; immunomodulation in cats with FeLV and/or FIV infection (clinical value of treatment is not established)3 million--unit pre-filled syringeCat: 30 units/cat/day PO or high dose: 10,000-1,000,000 units/cat SQ q24h\
IM or SQ once daily for 7 days and repeated every other wkIpecac syrup (OTC)IpecacOral emetic*No longer recommended:* can cause fatal arrhythmiasIpodateBilivist, OragrafinOrganic iodine; treatment of hyperthyroidism (especially in cats)500-mg capsule (should be formulated for cats as 50-mg ampule)Dog: 15 mg/kg PO q12h\
Cat: 100-200 mg (total dose)/cat once daily; dose may be reduced if the 2-wk response is judged satisfactoryIronSee *Ferrous sulfate*§ IsofluraneIsoflurane, Forane, Aerrane, othersInhalation anesthetic100-mL bottleInduction: 5%\
Maintenance: 1.5%-2.5%§ IsoproterenolIsuprelβ-Agonist; uncommonly used to treat acute bronchoconstriction and certain cardiac arrhythmias0.2 mg/mL ampule for injection10 mcg/kg IM, SQ q6h; or dilute 1 mg in 500 mL of 5% dextrose or Ringer\'s solution and infuse IV 0.5-1 mL/min (1-2 mcg/min) or to effect§ Isosorbide dinitrateIsordil, Isorbid, SorbitrateVasodilator; congestive heart failure2.5-, 5-, 10-, 20-, 30-, and 40-mg tablets; 40-mg capsules2.5-5 mg/animal PO q12h (or 0.22- 1.1 mg/kg PO q12h)§ Isosorbide mononitrateMonoketVasodilator; congestive heart failure10- and 20-mg tablets5 mg/dog PO, two doses/day 7 hr apartIsotretinoinAccutaneSynthetic retinoid; treatment of dermatologic diseases associated with epithelial cell proliferation (e.g., ichthyosis, cutaneous lymphoma)10-, 20-, and 40-mg capsules1-3 mg/kg/day (up to maximum recommended dose of 3-4 mg/kg/ day PO)ItraconazoleSporanoxAntifungal; treatment of systemic mycoses100-mg capsuleDog: 2.5 mg/kg PO q12h or 5 mg/kg\
PO q24h\
Cat: 1.5-3.0 mg/kg PO up to 10 mg/kg PO q24hIvermectinHeartgard, Ivomec, Eqvalan liquidAntiparasiticide; multiple applications1% (10 mg/mL) injectable solution; 10 mg/mL oral solution; 18.7 mg/mL oral paste; 68-, 136-, and 272-mcg tabletsHeartworm preventative :\
Dog: 6 mcg/kg (range: 3 to 12 mcg/kg) PO q30days\
Cat: 24 mcg/kg PO q30days\
Microfilaricide: 50 mcg/kg PO 2 wk after adulticide therapy\
Ectoparasite therapy (dog and cat): 200-300 mcg/kg IM, SQ, PO\
Endoparasites (dog and cat): 200-400 mcg/kg SQ, PO weekly\
*Demodex* therapy: start at 100 mcg/kg/day PO q24h, increase by 100 mcg/kg increments weekly to biweekly until target of 600 mcg/kg is reachedKanamycinKantrimAntibacterial200 and 500mg/mL injection10 mg/kg IV, IM, SQ q6-8h§ Kaopectate (kaolin + pectin) (OTC)KaopectateGI adsorbent; management of acute, simple diarrheal disorders, especially result of dietary indiscretion12-oz oral suspension1-2 mL/kg PO q2-6h§ KetamineKetalar, Ketavet, VetalarDissociative anesthetic100 mg/mL injection solutionDog: 5.5-22 mg/kg IV, IM (recommend adjunctive sedative or tranquilizer treatment)\
Cat: 2-25 mg/kg IV, IM (recommend adjunctive sedative or tranquilizer treatment)KetoconazoleNizoralAntifungal; systemic mycoses, *Malassezia canis* infection; limited application in the treatment of canine hyperadrenocorticism200-mg tablet; 100 mg/mL oral suspension (available only in Canada)Dog: 10-15 mg/kg PO q8-12h\
*Malassezia canis:* 10 mg/kg PO q24h or 5 mg/kg PO q12h)\
Cat: 5-10 mg/kg PO q8-12h\
Hyperadrenocorticism: Dog: 15 mg/kg PO q12h§ KetoprofenOrudis KT (OTC), KetofenNSAID; pain management12.5-mg tablet (OTC); 100 mg/mL injectionDog and cat: 1 mg/kg PO q24h for up to 5 days or 2.0 mg/kg IV, IM, SQ for one doseKetorolac tromethamineToradolNSAID; pain management10-mg tablet; 15 and 30 mg/mL injection in 10% alcoholDog: 0.5 mg/kg PO, IM, IV q12h for not more than two doses\
Cat: 0.25 mg/kg IM q8-12h for 1-2 doses§ Lactated Ringer\'s solutionGenericFluid replacement250-, 500-, and 1000-mL bagsMaintenance: 40-50 mL/kg/day IV\
Shock therapy:\
Dog: 90 mL/kg IV\
Cat: 60-70 mL/kg IV§ LactuloseChronulac, genericDisaccharide laxative; limits bowel absorption of protein and facilitates lowering of blood ammonia levels in patients with hepatic encephalopathy10 g/15 mLConstipation: 1 mL/4.5 kg PO q8h (to effect)\
Hepatic encephalopathy:\
Dog: 0.5 mL/kg PO q8h\
Cat: 2.5-5 mL/kg PO q8h§ Leucovorin (folinic acid)Wellcovorin, genericAntidote; folic acid antagonism; application in dogs and cats is not established5-, 10-, 15-, and 25-mg tablets; 3 and 5 mg/mL injectionWith methotrexate administration: 3 mg/m^2^ IV, IM, PO\
Antidote for pyrimethamine toxicosis: 1 mg/kg PO q24hLevamisoleLevasole, Tramisol injectableAntiparasitic; treatment of nematode infection; also proposed to be a nonspecific immunostimulant0.184-g bolus; 11.7-g/13-g packet; 50-mg tabletDog:\
Hookworms: 5-8 mg/kg PO once (up to 10 mg/kg PO for 2 days)\
Microfilaricide: 10 mg/kg PO q24h for 6-10 days\
Immunostimulant: 0.5-2 mg/kg PO 3 times/wk\
Cat: 4.4 mg/kg once PO (for lungworms: 20-40 mg/kg PO q48h for five treatments)LevetiracetamKeppraOral anticonvulsant250-, 500-, and 750-mg tabletsDog: initially 20 mg/kg PO q8h, then gradually increase as needed to control seizures\
Cat: 30 mg/kg PO q12h (look for an underlying cause of seizure activity)L-dopa, LevodopaLarodopa, (multiple products available)Dopamine agonist; hepatic encephalopathy100-, 250-, and 500-mg tablets or capsulesHepatic encephalopathy: 6.8 mg/kg initially, then 1.4 mg/kg q6hLevothyroxine sodium (T~4~)Soloxine, Thyro-Tabs, SynthoidHormone; hypothyroidism0.1- to 0.8-mg tablets (in 0.1-mg increments)Dog: 18-22 mcg/kg PO q12h (adjust dose via monitoring T~4~ levels)\
Cat: 10-20 mcg/kg/day, PO (adjust dose via monitoring T~4~ levels)§ Lidocaine (without epinephrine)Xylocaine, genericAnesthetic and antiarrhythmic; ventricular arrhythmias; also local and regional anesthetic; has been used systemically for pain5, 10, 15, and 20 mg/mL injectionDog (antiarrhythmic): 2-4 mg/kg IV (to a maximum dose of 8 mg/kg over 10-min period); 25-75 mcg/kg/min intravenous infusion\
Cat (antiarrhythmic): 0.25-0.75 mg/kg\
IV slowly\
For epidural (dog and cat): 4.4 mg of 2% solution per kilogramLincomycinLincocinAntibacterial100-, 200-, and 500-mg tablets15-25 mg/kg PO q12h\
For pyoderma: Doses as low as 10 mg/kg q12h have been usedLiothyronine (T~3~)CytomelHormone (active form of T~3~); replacement therapy in patients with hypothyroidism that fail to respond to T~4~60-mcg tablet4.4 mcg/kg PO q8h\
For T~3~ suppression test (cats): Collect presample for T~4~ and T~3~; administer 25 mcg q8h for 7 doses; then collect postsamples for T~3~ and T~4~ after last doseLisinoprilPrinivil, ZestrilACE inhibitor; vasodilator for treatment of hypertension or heart failure2.5-, 5-, 10-, 20-, and 40-mg tabletsDog: 0.5 mg/kg PO q24h\
Cat: 0.25-0.5 mg/kg PO q24hLithium carbonateLithotabsNonspecific immunostimulant; adjunctive treatment to increase neutrophil counts in patients with chemotherapy-induced neutropenia150-, 300-, and 600-mg capsules; 300-mg tablet; 300 mg/5 mL syrupDog: 10 mg/kg PO q12h\
Cat: Not recommendedLoperamideImodium, genericAnalgesic (opiate); nonspecific management of diarrhea2-mg tablet; 0.2 mg/mL oral liquidDog: 0.1 mg/kg PO q8-12h\
Cat: 0.08-0.16 mg/kg PO q12hLufenuronProgramAntiparasitic; flea control45-, 90-, 135-, 204.9-, and 409.8-mg tablets; 135- and 270-mg suspension per unit packDog: 10/mg/kg PO q30days\
Cat: 30 mg/kg PO q30days; 10 mg/kg\
SQ q6moLufenuron + milbemycin oximeSentinel tablets, Flavor TabsAntiparasitic; flea control plus heartworm preventative effective against certain intestinal parasitesMilbemycin-lufenuron ratio is as follows: 2.3/46 mg, Sentinel tablets; 5.75/115, 11.5/230, and 23/460 mg, Flavor TabsDog: Administer 1 tablet q30days as recommended by manufacturer (each tablet formulated for size of dog)\
Cat: *Do not use*Luteinizing hormoneSee *Gonadorelin*[l]{.smallcaps}-Lysine (OTC)Multiple preparationsAmino acid; prevention of feline herpesvirus-1 recrudescence250- 500-mg capsulesCat (empiric dose): Mix 250 to 500 mg with food once daily. Kittens receive approximately 250 mg daily, with food.\
*Note:* Efficacy studies have not been performed; agent has no known effect on feline calicivirus carrier cats.§ Magnesium chlorideGenericElemental salt; ventricular dysrhythmias, refractory hypokalemia, and ventricular fibrillation200 mg/mL in 50-mL vials for injection0.15-0.3 mEq/kg IV over 2-10 min; or 0.75 mEq/kg/day IV by CRIMagnesium citrateCitroma, Citro-Nesia (Citro-Mag in Canada)LaxativeOral solution2-4 mL/kg POMagnesium hydroxide (OTC)Multiple products availableLaxativeOral liquidAntacid: 5-10 mL/kg PO q4-6h\
Cathartic:\
Dog: 15-50 mL/kg PO\
Cat: 2-6 mL/cat PO q24hMagnesium sulfate (OTC)Multiple products availableLaxative; also used for oral magnesium supplementationCrystals; many generic preparationsDog: 8-25 g/dog PO q24h\
Cat: 2-5 g/cat PO q24h§ MannitolOsmitrolDiuretic (osmotic); management of anuric and/or oliguric renal failure; applications in management of glaucoma (repeat in 6 hr if necessary) and cerebral edema5%-25% solution for injectionDiuretic: 1 g/kg 5%-25% solution IV to maintain urine flow\
Glaucoma or CNS edema: 0.25-2 g/kg 15%-25% solution IV over 30-60 minMarbofloxacinZeniquinAntibacterial25-, 50-, 100-, 200-mg tabletsDog: 2.75-5.55 mg/kg PO q24h\
Cat: Dose not establishedMaropitantCereniaAntiemetic (parenteral and oral); oral administration to prevent motion sickness in dogs10 mg/mL solution for injection; 16-, 24-, 60-, and 160-mg tabletsDog: 1 mg/kg SQ once daily for up to 5 days; 2 mg/kg PO once daily for up to 5 days\
For motion sickness: 8 mg/kg PO once daily for up to 2 days\
Cat: Dose not establishedMCT (medium chain triglyceride) oilMultiple OTC products availableMedium-chain triglyceride; lipid supplement used in patients with GI absorptive disordersOral liquid1-2 mL/kg/day in foodMebendazoleTelminticAntiparasitic; multiple applications for treatment of endoparasites40 mg/powder22 mg/kg (with food) q24h for 3 days§ MeclizineAntivert, genericAntihistamine, antiemetic, especially when nausea is associated with vertigo12.5-, 25-, and 50-mg tabletsDog: 25 mg PO q24h (for motion sickness, administer 1 hr before traveling)\
Cat: 12.5 mg PO q24hMeclofenamateArquel, MeclomenNSAID; pain management50- and 100-mg capsulesDog: 1 mg/kg/day PO for up to 5 days§ MedetomidineDomitorAnalgesic (parenteral); adjunct for anesthesia, restraint1.0 mg/mL injection750 mcg/m^2^ IV or 1000 mcg/m^2^ IMMedium-chain triglyceridesSee *MCT oil*Medroxyprogesterone acetateDepo-Provera (injection), Provera (tablets)Hormone; management of certain dermatologic and behavior disorders, including urine spraying in cats; benign prostatic hyperplasia150 and 400 mg/mL suspension injection; 2.5-, 5-, and 10-mg tablets1.1-2.2 mg/kg IM q7days\
Behavior disorders: 10-20 mg/kg SQ or IM q3 months (dogs and cats)\
Prostatic hyperplasia: 3-5 mg/kg SQ, IMMegestrol acetateOvaban, MegaceHormone; management of certain dermatologic and behavior disorders, including urine spraying in cats5-mg tabletDog:Proestrus: 2 mg/kg PO q24h for 8 days\
Anestrus: 0.5 mg/kg PO q24h for 30 days\
Behavior disorders: 2-4 mg/kg q24h for 8 days (reduce dose for maintenance)\
Cat (*Note:* Any use in cats is *extra- label*):\
Dermatologic therapy or urine spraying: 2.5-5 mg/cat PO q24h for 1 wk, then reduce to 5 mg once or twice per week\
Estrus suppression: 5 mg/cat/day for 3 days, then 2.5-5 mg once/wk for 10 wkMelarsomineImmiticideAntiparasitic (arsenical); treatment of canine heartworm disease25 mg/mL injection; after reconstitution, retains potency for 24 hrAdminister via deep intramuscular injection\
Class 1-2 dogs: 2.5 mg/kg/day for 2 consecutive days\
Class 3 dogs: 2.5 mg/kg once, then in 1 mo two additional doses 24 hr apart\
Cat: *Do not use*§ MeloxicamMetacamNSAID; pain management1.5 mg/mL oral solution0.2 mg/kg PO initial loading dose; then 0.1 mg/kg PO q12hMelphalanAlkeranAntineoplastic; used in treatment protocols for multiple tumor types2-mg tablet1.5 mg/m^2^ or 0.1-0.2 mg/kg PO q24h for 7-10 days; repeat every 3 wkMeperidineDemerolAnalgesic (opiate); pain management50- and 100-mg tablets; 10 mg/mL syrup; 25, 50, 75, and 100 mg/mL injectionDog: 5-10 mg/kg IV, IM as often as q2-3h (or as needed)\
Cat: 3-5 mg/kg IV, IM q2-4h (or as needed)MepivacaineCarbocaine-VLocal anesthetic2% (20 mg/mL) injectionVariable dose for local infiltration\
For epidural, 0.5 mg of 2% solution q30sec until reflexes are absent6-MercaptopurinePurinetholAntineoplastic; used in treatment protocols for multiple tumor types50-mg tablet50 mg/m^2^ PO q24h\
*Caution:* Consult treatment protocol before administering.MeropenemMerremAntibacterial; especially in treating resistant infections caused by *Pseudomonas, Escherichia coli,* and *Klebsiella*500 mg in 20-mL vial, or 1 g in 30-mL vial for injection20 mg/kg IV q8h\
For meningitis: 40 mg/kg IV q8hMetaproterenolAlupent, Metaprelβ-Agonist; bronchodilator therapy10- and 20-mg tablets; 5 mg/mL syrup; inhalers0.325-0.65 mg/kg PO q4-6hMetforminGlucophageOral hypoglycemic; management of type 2 diabetes in cats500- and 800-mg tabletsCats: 2 mg/kg PO q12hMethazolamideNeptazaneCarbonic anhydrase inhibitor; treatment of open-angle glaucoma25- and 50-mg tablets2-4 mg/kg (up to maximum dose of 4-6 mg/kg) PO q8-12hMethenamine hippurateHiprex, UrexUrinary antiseptic (of questionable value)1-g tabletDog: 500 mg/dog PO q12h\
Cat: 250 mg/cat PO q12hMethenamine mandelateMandelamine, genericUrinary antiseptic (of questionable value)1-g tablet; granules for oral solution; 50 and 100 mg/mL oral suspension10-20 mg/kg PO q8-12hMethimazoleTapazoleAntithyroidal; management of feline hyperthyroidism5- and 10-mg tabletsCat: 2.5 mg/cat q12h PO for 7-14 days; then 5-10 mg/cat PO q12h and adjust by monitoring T~4~Methionine ([dl]{.smallcaps})Uroeze; [dl]{.smallcaps}-methionine powderUrinary acidifier500-mg tablets and powders added to animal\'s food; 75 mg/ 5 mL pediatric oral solution; 200-mg capsuleDog: 150-300 mg/kg/day PO\
Cat: 1-1.5 g/cat PO (added to food each day)Methionine (*S*-adenosyl)See *SAMe*§ MethocarbamolRobaxin-VMuscle relaxant; adjunctive therapy for trauma, acute inflammation of skeletal muscle, and/or tremorgenic toxins500- and 750-mg tablets; 100 mg/mL injection44 mg/kg PO q8h on the first day; then 22-44 mg/kg PO q8hMethohexitalBrevitalUltra-short-acting barbiturate; anesthetic induction0.5-, 2.5-, and 5-g vials for injection3-6 mg/kg IV (give slowly to effect)MethotrexateMTX, Mexate, Folex, Rheumatrex, genericAntineoplastic; used in treatment protocols for multiple tumor types, especially lymphomas2.5-mg tablet; 2.5 or 25 mg/mL injection2.5-5 mg/m^2^ PO q48h (dose depends on specific protocol) or:\
Dog: 0.3-0.5 mg/kg IV once/wk\
Cat: 0.8 mg/kg IV q2-3wk§ MethoxamineVasoxylVasopressor; used in critical care setting to increase blood pressure20 mg/mL injection200-250 mcg/kg IM or 40-80 mcg/kg IV§ Methylene blue 0.1%Generic; also called *new methylene blue*Antidote; emergency treatment of methemoglobinemia1% solution (10 mg/mL)1.5 mg/kg IV slowly; use onceMethylprednisoloneMedrolGlucocorticoid; antiinflammatory and immunosuppressive1-, 2-, 4-, 8-, 18-, and 32-mg tabletsIn cats, *use with caution:* 0.22-0.44 mg/kg PO q12-24h\
*Note:* Methylprednisolone is 1.25 times more potent than prednisolone.Methylprednisolone acetateDepo-MedrolRepository glucocorticoid; antiinflammatory (extended duration of activity)20 and 40 mg/mL suspension for injectionDog: 1 mg/kg (or 20-40 mg/dog) IM q1-3wk\
Cat: 10-20 mg/cat IM q1-3wk\
*Note:* Actual dose may vary, depending on use and effect.§ Methylprednisolone sodium succinateSolu-MedrolGlucocorticoid; adjunctive treatment for patients in shock or with spinal cord trauma or swelling1- and 2-g and 125- and 500-mg vials for injectionFor emergency use: 30 mg/kg IV; repeat at 15 mg/kg IV in 2-6 hr\
For replacement therapy or antiinflammatory therapy; see also *Prednisolone*§ 4-Methylpyrazole (4-MP)See *Fomepizole*MethyltestosteroneAndroid, genericHormone; replacement therapy; also an anabolic agent used to induce erythropoiesis10- and 25-mg tabletsDog: 5-25 mg/dog PO q24-48h\
Cat: 2.5-5 mg/cat PO q24-48h§ MetoclopramideReglan, Maxolon, othersAntiemetic, especially in patients with vomiting associated with gastroparesis5- and 10-mg tablets; 1 mg/mL oral solution; 5 mg/mL injection0.2-0.5 mg/kg IV, IM, PO q6-8h; or 1-2 mg/kg/day IV by CRI (approximately 0.01-0.02 mg/kg/hr)MetoprololLopressorβ-Blocker; management of tachycardia50- and 100-mg tablets; 1 mg/mL injectionDog: 5-50 mg/dog (0.5-1.0 mg/kg) PO q8h\
Cat: 2-15 mg/cat PO q8h§ MetronidazoleFlagyl, genericAntiparasitic and antibacterial; effective against anaerobic bacteria; somewhat effective against *Giardia* (fenbendazole is preferred)250- and 500-mg tablets; 50 mg/mL suspension; 5 mg/mL injectionAnaerobic infection:\
Dog: 15 mg/kg PO q12h or 12 mg/kg q8h\
Cat: 10-25 mg/kg PO q12h\
*Giardia:* Dog: 12-15 mg/kg PO q12h for 8 days\
Cat: 25 mg/kg q12h for 8 days§ MexiletineMexitilAntiarrhythmic; ventricular arrhythmias150-, 200-, and 250-mg capsulesDog: 5-8 mg/kg PO q8-12h *(Use cautiously.)*\
Cat: No dose establishedMiboleroneCheque DropsHormone (androgenic); suppression of estrus and treatment of false pregnancy (pseudocyesis)55 mcg/mL oral solutionDog: 0.45-11.3 kg, 30 mcg; 11.8-22.7 kg, 60 mcg; 23-43.3 kg, 120 mcg; \>45.8 kg, 180 mcg; or approximately 2.6-5 mcg/kg/day PO\
Cat: *Do not use Warning:* Multiple adverse effects are possible when used in prepubertal females.§ MidazolamVersedBenzodiazepine; preanesthetic medication5 mg/mL injection0.1-0.25 mg/kg IV, IM (or 0.1-0.3 mg/kg/hr intravenous infusion)\
*Note:* May cause excitement in catsMilbemycin oximeInterceptor; Interceptor Flavor TabsGABA inhibitor; prevention of canine heartworm disease, microfilaricide; also used to treat demodicosis23-, 11.5-, 5.75-, and 2.3-mg tabletsDog:\
Microfilaricide: 0.5 mg/kg\
*Demodex:* 2 mg/kg PO q24h for 60-120 days\
Heartworm prevention: 0.5-0.99 mg/kg PO q30 daysMilk of magnesia (OTC)See *Magnesium* hydroxideMineral oil (OTC)GenericLaxative (lubricant)Oral liquidDog: 10-50 mL/dog PO q12h\
Cat: 10-25 mL/cat PO q12hMinocyclineMinocinAntibacterial50- and 100-mg tablets; 10 mg/mL oral suspension5-12.5 mg/kg PO q12h§ MisoprostolCytotecProstaglandin E~1~ analogue; treatment of gastric ulcers, especially those associated with NSAID use0.1-mg (100-mcg) and 0.2-mg (200-mcg) tabletsDog: 2-5 mcg/kg PO q6-8h\
Cat: Dose not establishedMitotane (o,p′-DDD)LysodrenCytotoxic agent; treatment of hyperadrenocorticism associated with adrenal hyperplasia; less effective if treating adrenal gland neoplasia500-mg tabletDog: Pituitary-dependent hyperadrenocorticism: 50 mg/kg/day (in divided doses) PO for 7-10 days, then 25 mg/kg/wk PO\
Adrenal neoplasia: 50-75 mg/kg PO q12h for 10 days, then 75-100 mg/kg PO divided doses q12hMitoxantroneNovantroneAntineoplastic; used in treatment protocols for multiple tumor types2 mg/mL injectionDog: 6 mg/m^2^ IV q21days\
Cat: 6.5 mg/m^2^ IV q21days§ MorphineGenericAnalgesic (opiate); pain management1 and 15 mg/mL injection; 30- and 60-mg delayed-release tabletsDog: 0.1-1 mg/kg IV, IM, SQ (dose is escalated as needed for pain relief) q4-6h Epidural: 0.1 mg/kg\
Cat: 0.1 mg/kg q3-6h IM, SQ (or as needed)§ NaloxoneNarcanOpiate antagonist; opiate reversal20 and 400 mcg/mL injection0.01-0.04 mg/kg IV, IM, SQ as needed to reverse opiateNaltrexoneTrexanOpiate antagonist; management of certain behavioral disorders (e.g., tail chasing, self-mutilation)50-mg tabletDog: 2.2 mg/kg PO q12hNandrolone decanoateDeca-DurabolinAnabolic steroid; appetite stimulant; also used to stimulate erythropoiesis50, 100, and 200 mg/mL injectionDog: 1-1.5 mg/kg/wk IM\
Cat: 10-20 mg/cat/wk IMNaproxenNaprosyn, Naxen, Aleve (naproxen sodium)NSAID; pain management220-mg tablet (OTC); 25 mg/mL suspension liquid; 250-, 375-, and 500-mg tablets (prescription)Dog: 5 mg initially, then 2 mg/kg q48hNeomycinBiosolAntibacterial; management of hepatic encephalopathy (gut "sterilization")500-mg bolus; 200 mg/mL oral liquid10-20 mg/kg PO q6-12hNeostigmine bromide and neostigmine methylsulfateProstigmin, StiglynAnticholinesterase; diagnosis of myasthenia gravis; antidote for anticholinergic intoxication and massive ivermectin overdose in cats15-mg tablet (neostigmine bromide); 0.25 and 0.5 mg/mL injection (neostigmine methylsulfate)\
Injection: antimyasthenic: 4 mcg/kg IM, SQ, as needed; antidote for nondepolarizing neuromuscular block: 10 mcg/kg IM, SQ; diagnostic aid for myasthenia gravis: 40 mcg/kg IM or 20 mcg/kg IVNitrofurantoinMacrodantin, Furalan, Furatoin, Furadantin, and genericAntibacterial, especially in susceptible urinary tract infectionsMacrodantin and generic: 25-, 50-, and 100-mg capsules\
Furalan, Furatoin, and generic: 50- and 100-mg tablets\
Furadantin: 5 mg/mL oral suspensionSusceptible UTI = 4 mg/kg PO every 6 hours\
Prophylactic dose = 3-4 mg/kg PO q24 hours (at night immediately before bedtime)§ NitroprussideNitropressVascular and smooth muscle relaxant; acute hypertension, acute heart failure secondary to mitral regurgitation50-mg vial for injectionHypertensive crisis: initiate dose at 1-2 mcg/kg/min IV, increase dose incrementally every 3-5-min until target BP is attained Adjunctive rx for heart failure: 0.5-10 mcg/ kg/min IV at a low fluid rate (\< = 2mL/kg/hr)NizatidineAxidH~2~-receptor antagonist; reduction of gastric acid production and prevention of gastric ulcers150- and 300-mg capsules2.5-5.0 mg/kg PO once dailyNorfloxacinNoroxinAntibacterial400-mg tablet22 mg/kg PO q12hOlsalazineDipentumAntidiarrheal; alternative drug to sulfasalazine for management of colitis in dogs (expensive)500-mg tabletDosage in animals is not established.\
Dog: 5-10 mg/kg PO q8h is recommendedOmeprazolePrilosec (formerly Losec), Gastrogard (equine paste)Proton pump inhibitor; gastric ulceration and erosion20-mg capsuleDog: 20 mg PO once daily (if \<20 kg use 0.7 mg/kg q24h)\
Cat: 0.7 mg/kg PO once daily§ OndansetronZofran5-HT3 receptor antagonist; antiemetic for patients with severe vomiting\
*Note:* Is well tolerated in dogs4- and 8-mg tablets; 2 mg/mL injection0.1-1.0 mg/kg PO 30 min before cancer chemotherapy\
For intractable vomiting: 0.11 to 0.176 mg/kg IV, slow pushOrbifloxacinOrbaxAntibacterial5.7-, 22.7-, and 68-mg tablets2.5 to 7.5 mg/kg PO once dailyOrmetoprim + sulfadimethoxinePrimorAntibacterialCombination tablet: 120-, 250-, 600-, and 1200-mg tabletsInitially 55 mg/kg (combined drug) PO on the first day of therapy, then 27.5 mg/kg PO once daily for at least 2 days after remission of clinical signs (not approved for treatment \>21 days)OxacillinProstaphlin, genericAntibacterial250- and 500-mg capsules; 50 mg/mL oral solution22-40 mg/kg PO q8hOxazepamSeraxBenzodiazepine; appetite stimulant15-mg tabletCat: Appetite stimulant: 2.5 mg/cat POOxtriphyllineCholedyl SABronchodilator; chronic bronchitis (feline asthma?)400- and 600-mg tablets (oral solutions and syrup available in Canada but not United States)Dog: 47 mg/kg (equivalent to 30 mg of theophylline per kilogram) PO q12h\
Cat: Dose not availableOxybutyninDitropanUrinary antispasmodic; adjunctive treatment of detrusor hyperreflexia (includes FeLV-positive cats)5-mg tabletDog: 0.2 mg/kg PO q8-12h (or 1.25-3.75 mg/dog q12h)\
Cat: 0.5-1.0 mg/kg (total dose) PO q8-12hOxymetholoneAnadrolHormone (anabolic steroid); may stimulate erythropoiesis50-mg tablet1-5 mg/kg/day POOxymorphoneNumorphanAnalgesic (opiate); pain management1.5 and 1 mg/mL injectionAnalgesia: 0.1-0.2 mg/kg IV, SQ, IM (as needed); re-treat with 0.05-0.1 mg/kg q1-2h. Preanesthetic: 0.025-0.05 mg/kg\
IM, SQOxytetracyclineTerramycinAntibacterial250-mg tablets; 100 and 200 mg/mL injection7.5-10 mg/kg IV q12h; 20 mg/kg PO q12hOxytocinPitocin, Syntocinon (nasal solution), genericHormone; induction of labor or parturition10 and 20 units/mL injection; 40 units/mL nasal solutionDog: 5-20 units/dog SQ, IM (repeat every 30 min for primary inertia)\
Cat: 0.25-1 units SC or IM every 30-60 min2-PAMSee *Pralidoxime chloride*Pancreatic enzymesViokaseDigestive enzymes; management of exocrine insufficiency16,800 units lipase, 70,000 units protease, and 70,000 units amylase per 0.7 g; also capsules and tabletsMix 2 tsp powder with food per 20 kg; body weight or 1-3 tsp/0.45 kg of food 20 min before feedingPancuronium bromidePavulonNeuromuscular blocker; muscle relaxation as an adjunct to anesthesia1 and 2 mg/mL injection0.1 mg/kg IV, or start with 0.01 mg/kg and additional doses of 0.01 mg/kg q30minParegoricCorrective mixtureAntidiarrheal; management of simple diarrhea2 mg morphine per 5 mL paregoric0.05-0.06 mg/kg PO q12hParomomycinHumatinAntiparasitic; cryptosporidiosis in cats250-mg capsuleCat: 125-165 mg/kg PO q12h for 7 days.\
*Warning:* Toxicity and renal damage have been reported at these doses.ParoxetinePaxilSSRI; management of behavior disorders10-, 20-, 30-, and 40-mg tabletsDog: 1 mg/kg up to 3 mg/kg\
PO once daily\
Cat: 2.5-5 mg total dose PO once daily[d]{.smallcaps}-PenicillamineCuprimine, DepenChelating agent; treatment of lead poisoning; also for cystine urolithiasis125- and 250-mg capsules and 250-mg tablet10-15 mg/kg PO q12hNote: Take on an empty stomach and without other medicinesPenicillin G benzathineBenza-Pen, othersAntibacterial150,000 units/mL, combined with 150,000 units/mL procaine, penicillin G40,000 IU/kg IM q5 daysPenicillin G potassium; penicillin G sodiumMultipleAntibacterial5 million-- to 20 million--unit vials20,000-40,000 units/kg IV, IM q6-8hPenicillin G procaineGenericAntibacterial300,000 units/mL suspension20,000-40,000 units/kg SC, IM q12-24hPenicillin VPen-VeeAntibacterial250- and 500-mg tablets10 mg/kg PO q8hPentazocineTalwin-VAnalgesic (opiate); pain management30 mg/mL injectionDog: 1.65-3.3 mg/kg IM q4h\
Cat: 2.2-3.3 mg/kg IV, IM, SQ q4h (due to dysphoria, pentazocine is not recommended in cats)§ PentobarbitalNembutal, genericAnesthetic; sedative or injectable anesthetic50 mg/mL *Note:* This formulation is *not* to be used for euthanasia.Anesthesia: 10-30 mg/kg IV to effectPentoxifyllineTrentalAntiinflammatory effects; has been used to treat immune-mediated skin disorders (e.g., associated with vasculitis) in dogs400-mg tabletDog: For use in canine dermatology and for systemic or regional vasculitis, 10 mg/kg PO q12h§ PhenobarbitalLuminal and genericBarbiturate; sedation and anticonvulsant15-, 30-, 60-, and 100-mg tablets; 30, 60, 65, and 130 mg/mL injection; 4 mg/mL oral elixir solutionDog: 2-8 mg/kg PO q12h\
Cat: 2-4 mg kg PO q12h\
Dog and cat: Adjust dose by monitoring plasma concentration\
Status epilepticus: administer in increments of 10-20 mg/kg IV to effectPhenoxybenzamineDibenzylineα-Adrenergic blocker; reduces internal urethral sphincter tone associated with detrusor areflexia; also hypertension associated with pheochromocytoma10-mg capsuleDog:\
Urinary: 0.25 mg/kg PO 12-24h or 0.5 mg/kg q24h\
Hypertension: 0.2-1.5 mg/kg, PO bid for 10-14 days before surgery Cat: 2.5 mg/cat q8-12h or 0.5 mg/cat PO q12h\
*Note:* In cats, doses as high as 0.5 mg/kg\
IV have been used to relax urethral smooth musclePhentolamineRegitineVasodilator; hypertension5-mg vial for injection0.02-0.1 mg/kg IVPhenylbutazoneButazolidin, genericNSAID100-, 200-, 400-mg and 1-g tablets; 200 mg/mL injection*Not* recommended for use in dogs and cats (better drugs are available)§ PhenylephrineNeo-Synephrineα-Adrenergic; treatment of hypotension in the critical care setting; also used topically intranasally before rhinoscopy10 mg/mL injection; 1% nasal solutionDog and cat: 1-3 mcg/kg/min CRI in 0.9% saline or D5W; 0.1 mg/kg IM, SQ q15min\
Topical: 3-5 drops intranasally to effect to induce local vasoconstrictionPhenylpropanolamineDexatrim, Propagest, othersAdrenergic agonist; urinary incontinence associated with urethral sphincter hypotonus15-, 25-, 30-, and 50-mg tablets\
Dog: 12.5-50 mg (total) PO q8h or 1.5-2 mg/kg PO q12hCat: 12.5 mg (total) PO q8h or 1.5 mg/kg\
PO q8hPhenytoinDilantinAnticonvulsant; not generally recommended; limited application in digoxin-induced arrhythmias30 and 1250 mg/mL oral suspension; 30- and 100-mg capsules; 50 mg/mL injectionAntiepileptic (dog): 20-34 mg/kg q8h\
Digoxin-induced antiarrhythmia: 30 mg/kg PO q8h or 10 mg/kg IV over 5 min§ Phenytoin + pentobarbitalBeuthanasia-D\
Special, EuthasolEuthanasia solution100-mL multiple-dose vials1 mL/10 lb body weight IV. *Note:* Alternative routes (at the same dosage) for sodium administration can be used in profoundly debilitated patients (e.g., intraperitoneal, intracardiac).PhysostigmineAntiliriumCholinesterase inhibitor/limited application; may be of use in promoting micturition in patients with urinary retention (postoperatively)1 mg/mL injection0.02 mg/kg IV q12h§ PhytomenadioneSee *Vitamin K*~1~§ PhytonadioneSee *Vitamin K*~1~PiperacillinPipracilAntibacterial2-, 3-, 4-, and 40-g vials for injection40 mg/kg IV or IM q6hPiperazineManyAntiparasitic; roundworms860 mg powder; 140-mg capsule, 170, 340, and 800 mg/mL oral solution44-66 mg/kg PO administered oncePiroxicamFeldene, genericNSAID; has antitumor effects (indirect) in patients with transitional cell carcinoma (palliative treatment)10-mg capsuleDog: 0.3 mg/kg PO once daily\
Cat: 0.3 mg/kg PO q24-72h\
(Administer with food)Pitressin (ADH)See *Vasopressin* and *Desmopressin acetate*Plicamycin (formerly mithramycin)MithracinAntineoplastic; adjunctive treatment in carcinoma protocols; also used to decrease calcium levels in hypercalcemic cancer patients2.5 mg/mL injectionDog: Antineoplastic: 25-30 mcg/kg/day IV (slow infusion) for 8-10 days\
Antihypercalcemic: 25 mcg/kg/day IV (slow infusion) over 4 hr\
Cat: *Not* recommendedPolyethylene glycol electrolyte solutionGoLYTELYLaxativeOral solution25 mL/kg PO; repeat in 2-4 hrPolysulfated glycosaminoglycan (PSGAG)Adequan CanineAntiarthritic; long-term management of osteoarthritis100 mg/mL injection in 5-mL vial (250 mg/mL vials for horses)4.4 mg/kg IM twice weekly for up to 4 wkPotassium bromide (KBr)No commercial formulationAnticonvulsant; long-term antiepileptic therapyUsually prepared as oral solutionDog and Cat: 30-40 mg/kg PO q24h\
*Note:* If administered without phenobarbital, higher doses of up to 40-50 mg/kg may be needed; adjust doses by monitoring plasma concentrations; loading doses of 400 mg/kg divided over 3 days have been administered.§ Potassium chloride (KCl)GenericPotassium salt; replacement therapyVarious concentrations for injection (usually 2 mEq/mL); oral suspension and oral solution0.5 mEq potassium/kg/day; or supplement 10-40 mEq/500 mL of fluids, depending on serum potassiumPotassium citrateUrocit-K and genericPotassium salt; replacement therapy5-mEq tablet; some forms are in combination with potassium chloride2.2 mEq/100 kcal of energy/day PO; or 0.5 mEq/kg per day POPotassium gluconateKaon; Tumil-K; genericPotassium source; replacement therapy2-mEq tablet; 500-mg tablet; Kaon elixir is 20 mg/15 mL elixirDog: 0.5 mEq/kg PO 12-24h\
Cat: 2-8 mEq/day PO divided twice daily§ Pralidoxime chloride (2-PAM)Protopam ChlorideCholinesterase reactivator; adjunctive treatment in patients with organophosphate toxicosis50 mg/mL injection20 mg/kg q8-12h (initial dose) IV slowly or IMPraziquantelDroncitAntiparasitic; treatment of cestodes (tapeworms)23- and 34-mg tablets; 56.8 mg/mL injectionDog IM/SC dosing: ≤5 lbs, 17 mg IM/SC; 6-10 lbs, 28.4 mg IM/SC; 11-25 lbs, 56.8 mg IM/SC\
Dog PO dosing: ≤5  lbs, 17 mg PO; 6-10 lbs, 34 mg PO; 11-15 lbs, 51 mg PO; 16-30 lbs, 68 mg PO; 31-45 lbs, 102 mg PO; 46-60 lbs, 136 mg PO; ≥60 lbs, 170 mg\
Cats IM/SC dosing: ≤5 lbs, 11.4 mg IM/SC; 5-10 lbs, 22.7 mg IM/SC; ≥11 lbs, 34.1 mg IM/SC\
Cats PO dosing: ≤4 lbs, 11.5 mg PO; 5-11 lbs, 23 mg PO; ≥11 lbs, 34.5 mg PO\
for Paragonimus: 23-25 mg/kg PO q8h for 3 days§ PrazosinMinipressα~1~-Blocker; adjunctive treatment of congestive heart failure; also hypertension and pulmonary hypertension (e.g., heartworm disease)1-, 2-, and 5-mg capsules0.5- and 2-mg/animal (1 mg/15 kg) PO q8-12h§ PrednisoloneDelta-Cortef; many othersGlucocorticoid; antiinflammatory and immunosuppressive5- and 20-mg tabletsDog (cat often requires 2 × dog dose):\
Antiinflammatory: 0.5-1 mg/kg IV, IM, PO q12-24h initially, then taper to q48h\
Immunosuppressive: 2.2-6.6 mg/kg/day IV, IM, PO initially, then taper to 2-4 mg/kg q48h\
Replacement therapy: 0.2-0.3 mg/kg/day PO\
Shock, spinal trauma: See *Prednisolone sodium succinate*§ Prednisolone sodium succinateSolu-Delta-CortefGlucocorticoid; adjunctive therapy for endotoxic or septic shock100- and 200-mg vials for injection (10 and 50 mg/mL)Shock: 5.5-11 mg/kg IV (repeat in 1, 3, 6, or 10 hr)\
CNS trauma: 15-30 mg/kg IV, then taper to 1-2 mg/kg q12h§ PrednisoneDeltasone and generic; Meticorten for injectionGlucocorticoid; antiinflammatory and immunosuppressive1-, 2.5-, 5-, 10-, 20-, 25-, and 50-mg tablets; 1 mg/mL syrup (Liquid-Pred in 5% alcohol); 1 mg/mL oral solution (in 5% alcohol); 10 and 40 mg/mL prednisone suspension for injectionSame as for prednisolonePrimidoneMylepsin; NeurosynAnticonvulsant; idiopathic epilepsy (not generally recommended)50- and 250-mg tablets8-10 mg/kg PO q8-12h as initial dose, then adjust via monitoring to 10-15 mg/kg q8h\
*Warning:* May cause irreversible liver disease with prolonged administration§ ProcainamidePronestyl and genericAntiarrhythmic; ventricular premature contractions (e.g., ventricular tachycardia)250, 375, 500 mg/mL injectionDog: 10-30 mg/kg PO q6h (up to maximum dose of 40 mg/kg); 8-20 mg/kg IV, IM; 25-50 mcg/kg/min IV infusion\
Cat: 3-8 mg/kg IM, PO q6-8hProcarbazineMatulane, Natulan, NatulanarAntineoplastic; component drug used in lymphoma protocols50-mg capsuleUsed in combination with mechlorethamine and prednisolone; consult latest information on protocols for precise doseProchlorperazineCompazinePhenothiazine; antiemetic5-, 10-, and 25-mg tablets (maleate); 5 mg/mL injection (edisylate)0.1-0.5 mg/kg IM, SQ q6-8hProgesterone, repositolSee *Medroxyprogesterone acetate*PromethazinePhenerganPhenothiazine; antiemetic6.25 and 25 mg/5 mL syrup; 12.5-, 25-, and 50-mg tablets; 25 and 50 mg/mL injectionAntiemetic: 2 mg/kg IM/PO once daily Antihistamine: 0.2-0.4 mg/kg IV/IM/PO q6-8h (up to max dose of 1 mg/kg)PropanthelinePro-BanthineAntimuscarinic, antidiarrheal; also used to treat urge incontinence associated with detrusor hyperreflexia; oral antiemetic effect7.5- and 15-mg tabletsDog: Urge incontinence: 0.2 mg/kg PO q6-8h\
Diarrhea: 0.25 mg/kg PO three times daily for 2-3 days max\
Cat: Urge incontinence: 0.25-0.5 mg/kg PO once or twice daily\
Chronic colitis: 0.5 mg/kg PO two to three times daily*Propionibacterium acnes* (injection)ImmunoRegulinNonspecific immunostimulant used as adjunctive therapy in dogs with pyoderma5 mL vialDog: Manufacturer\'s dosing recommendations: - up to 15 pounds: 0.25 mL IV. 16-45 pounds: 0.50 mL IV. 46-75 pounds: 1.0 mL IV. over 75 pounds: 2.0 mL IV.\
Product is not approved for use in cats.PropiopromazineTranvet, LargonAntiemetic, tranquilizer; sedation, parenteral antiemetic20 mg/mL injection1.1-4.4 mg/kg q12-24h PO or 0.1-1.1 mg/kg IV or IM (range depends on sedation needed)§ PropofolRapinovet, PropoFloShort-acting injectable anesthetic (hypnotic); induction or restraint for short-term procedures1% (10 mg/mL) injection in 20-mL ampules6.6 mg/kg IV slowly over 60 sec (CRIs have been used at 2 mg/kg/hr)§ PropranololInderal (other products are available)β-Blocker, antiarrhythmic10-, 20-, 40-, 60-, 80-, and 90-mg tablets; 1 mg/mL injection; 4 and 8 mg/mL oral solutionDog: 20-60 mcg/kg over 5-10 min IV; 0.2-1 mg/kg PO q8h (titrate dose to effect)\
Cat: 0.4-1.2 mg/kg (2.5-5 mg/cat) PO q8hPropylthiouracil (PTU)Propyl-Thyracil, genericAntithyroid; alternative drug used in the management of feline hyperthyroidism50- and 100-mg tabletsCat: 11 mg/kg PO q12hProstaglandin F~2~-alpha (dinoprost)LutalyseProstaglandin; open pyometra; pregnancy termination in dogs5 mg/mL solution for injection*Note:* Any use of this drug in dogs and cats is *extra-label.*\
Open pyometra:\
Dog: 0.1-0.2 mg/kg SQ once daily for 5 days\
Cat: 0.1-0.25 mg/kg SQ twice daily for 5 days\
*Note:* Concurrent antibiotic therapy is recommended. *Surgery is always preferred!*\
Abortion (within 30 days of the last unwanted breeding):\
Dog: 0.1 mg/kg SQ q8h for 2 days, then 0.2 mg/kg SQ q8h until abortion is confirmed by ultrasoundPseudoephedrineSudafed, many others (some formulations have other ingredients)Adrenergic agonist; urinary incontinence (generally only used when phenylpropanolamine is not available)30- and 60-mg tablets; 120-mg capsule; 6 mg/mL syrup0.2-0.4 mg/kg (or 15-60 mg/dog) PO (OTC) q8-12hPsylliumMetamucil, othersLaxative, stool softenerAvailable as powder1 tsp/5-10 kg (added to each meal)Pyrantel pamoate and tartrateNemex, StrongidAntiparasitic; treatment of ascarids and hookworms180 mg/mL paste and 50 mg/mL suspensionDog: 5 mg/kg PO once; repeat in 7-10 days\
Cat: 20 mg/kg PO oncePyridostigmine bromideMestinon, RegonolCholinesterase inhibitor; management of myasthenia gravis12 mg/mL oral syrup; 60-mg tablet; 5 mg/mL injectionAntimyasthenic: 0.02-0.04 mg/kg IV q2h, or 0.5-3 mg/kg PO q8-12h\
Antidote (nondepolarizing muscle relaxant): 0.15-0.3 mg/kg IM, IVPyrimethamineDaraprimFolic acid inhibitor; treatment of toxoplasmosis and neosporosis25-mg tabletDog: 1 mg/kg PO q24h for 14-21 days (5 days for *Neospora caninum*)\
Cat: 0.5-1 mg/kg PO q24h for 14-28 daysQuinacrineLimited availability in the United StatesAntiprotozoal; may be useful in management (not cure) of *Giardia* infections, leishmaniasis, and coccidiosis100-mg tabletDog: 6.6 mg/kg PO q12h for 5 days\
Cat: 11 mg/kg PO q24h for 5 daysQuinidine gluconateQuiniglute, DuraquinAntiarrhythmic; ventricular arrhythmias324-mg tablets; 80 mg/mL injectionDog: 6-20 mg/kg IM q6h; 6-20 mg/kg PO q6-8h (of base)Quinidine polygalacturonateCardioquinAntiarrhythmic; ventricular arrhythmias275-mg tabletDog: 6-20 mg/kg PO q6h (of quinidine base)\
*Note:* 275 mg quinidine polygalacturonate = 167 mg quinidine base.Quinidine sulfateCin-Quin, QuinoraAntiarrhythmic; ventricular arrhythmias100-, 200-, and 300-mg tablets; 200- and 300-mg capsules; 20 mg/mL injectionDog: 6-20 mg/kg PO q6-8h (of base); 5-10 mg/kg IV§ RanitidineZantacH~2~-receptor antagonist; treatment and prevention of gastric and duodenal ulcers75-, 150-, and 300-mg tablets; 150- and 300-mg capsules; 25 mg/mL injectionDog: 2 mg/kg IV, PO q8h\
Cat: 2.5 mg/kg IV q12h; 3.5 mg/kg\
PO q12hRetinolSee *Vitamin A*RiboflavinSee *Vitamin B*~2~RifampinRifadinAntibacterial (reported to have limited antifungal and antiviral activity)150- and 300-mg capsules10-20 mg/kg PO q8-12h§ Ringer\'s solutionGenericFluid replacement250-, 500-, and 1000-mL bags for infusion55-65 mL/kg/day (2.5 mL/kg/hr IV, SQ, IP maintenance)15-30 mL/kg/hr IV for moderate dehydration50 mL/kg/hr IV for severe dehydrationSalicylateSee *Aspirin*SAMe (*S*-adenosylmethionine)Denosyl-SD4Nucleotide-like molecule derived from the amino acid methionine; adjunctive therapy in patients with chronic liver diseaseEnteric-coated tablets20 mg/kg PO dailySelamectinRevolutionAntiparasitic (ivermectin); multiple applications in dogs and catsVarious sizes of topical solutions available for dogs and catsSee manufacturer\'s dosage instructions for the specific condition being treatedSelegilineAnipryl (also known as deprenyl and [l]{.smallcaps}-deprenyl)MAO-B inhibitor; canine cognitive dysfunction; reported use in treatment of canine hyperadrenocorticism (use in canine Cushing is currently *not* recommended)2-, 5-, 10-, 15-, and 30-mg tabletsDog: Begin with 1 mg/kg PO q24h; if no response within 2 mo, increase dose to maximum of 2 mg/kg PO q24h Cat: Dose not established.SennaSenokotLaxative; feline constipationGranules in concentrate, or syrupCat: syrup: 5 mL/cat q24h; granules ½ teaspoon/cat q24h (with food)SertralineZoloft, Altruline, Anilar, othersSSRI; management of certain behavior disorders in dogs25-, 50-, and 100-mg tablets; 20 mg/mL injectable in 60-mL vialsDog: 0.5-4.0 mg/kg q24h\
Cat: 0.5-1.0 mg/kg q24h§ Sodium bicarbonate (NaHCO--^3^) (OTC)Generic (e.g., baking soda, soda mint)Alkalinizing agent; management of acidosis and renal failure; also used to alkalinize urine when indicated325-, 520-, and 650-mg tablets; injection of various strengths (4.2% to 8.4%), and 1 mEq/mLAcidosis: 0.5-1 mEq/kg IV\
Renal failure: 10 mg/kg PO q8-12h\
Alkalization of urine: 50 mg/kg PO q8-12h (1 tsp is approximately 2 g)§ Sodium chloride 0.9%GenericFluid replacement (isotonic)500- and 1000-mL infusionModerate dehydration: 15-30 mL/kg/hr IV, severe dehydration 50 mL/kg/hr IV§ Sodium chloride 7.2%Generic (hypertonic)Fluid replacementInfusion2-8 mL/kg IV\
*Caution: Not* a balanced electrolyte solutionSodium iodide 20%Iodopen, genericIodine replacement; replacement for confirmed deficiencies100 mcg elemental iodide (118 mcg sodium iodide) per milliliter injection20-40 mg/kg PO q8-12hSotalolBetapaceNonselective β-blocker (antiarrhythmic); ventricular tachycardia80-, 160-, 240-mg tabletsDog: 1-2 mg/kg PO q12h (start with 40 mg/dog q12h, then increase to 80 mg if no response)\
Cat: 1-2 mg/kg PO q12hSpironolactoneAldactoneAldosterone antagonist; K-sparing diuretic used in the treatment of congestive heart failure; generally used in patients that do not respond to furosemide and ACE inhibitors25-, 50-, and 100-mg tablets2-4 mg/kg/day (or 1-2 mg/kg PO q12h)StanozololWinstrol-VAnabolic steroid; adjunctive therapy for no one really knows what; has been used to treat anemia of chronic disease50 mg/mL injection; 2-mg tabletDog: 2 mg/dog (or range of 1-4 mg/dog)\
PO q12h; 25-50 mg/dog/wk IM\
Cat: 1 mg/cat PO q12h; 25 mg/cat/wk IM\
*Caution:* Use in anorexic patients can cause weight loss (catabolic effect?).SuccimerChemetHeavy metal chelator; treatment of lead poisoning100-mg capsule10 mg/kg PO q8h for 5 days, then 10 mg/kg PO q12h for 2 more wk§ SucralfateCarafateAntiulcer treatment; treatment of gastric and duodenal ulcers (may have preventive effect)1-g tablet; 200 mg/mL oral suspensionDog: 0.5-1 g/dog PO q8-12h\
Cat: 0.25 g/cat PO q8-12hSufentanilSufentaAnalgesic (potent opiate); adjunct to anesthesia or epidural anesthesia50 mcg/mL injectionDogs: 3 mcg/kg IV (maximum dose is 5 mcg/kg IV)Cat: 0.1-0.5 mcg/kg IVSulfadiazineGeneric combined with trimethoprim in TribrissenAntibacterial500-mg tablet100 mg/kg IV PO (loading dose), followed by 50 mg/kg IV PO q12h (see also *Trimethoprim* + *sulfonamide*)SulfadimethoxineAlbon, Bactrovet, genericAntibacterial125-, 250-, and 500-mg tablets; 400 mg/mL injection; 50 mg/mL suspension55 mg/kg PO (loading dose), followed by 27.5 mg/kg PO once daily (see *Ormetoprim + sulfadimethoxine*)SulfamethazineMany brand name products (e.g., Sulmet)Antibacterial30-g bolus100 mg/kg PO (loading dose), followed by 50 mg/kg PO q12hSulfamethoxazoleGantanolAntibacterial50-mg tablet100 mg/kg PO (loading dose), followed by 50 mg/kg PO q12hSulfasalazine (sulfapyridine + mesalamine)AzulfidineAntibacterial and antiinflammatory activity; ulcerative colitis and other forms of inflammatory bowel disease in dogs500-mg tablets; pediatric suspensionDog: 10-30 mg/kg PO q8-12h\
*Warning:* Has been reported to cause keratoconjunctivitis sicca in dogsSulfisoxazoleGantrisinAntibacterial500-mg tablet; 500 mg/5 mL syrup50 mg/kg PO q8h (urinary tract infections)TaurineGenericAmino acid; taurine deficiency cardiomyopathiesAvailable in powderDog: 500 mg PO q12h\
Cat: 250 mg/cat PO q12-24hTepoxalinZubrinNSAID; management of pain associated with osteoarthritis in dogs30-, 50-, 100-, and 200-mg tabletsDog: 10-20 mg/kg PO on the first day; then 10 mg/kg PO once daily; thereafter as needed§ TerbutalineBrethine, Bricanylβ-agonist; bronchodilator; use includes feline asthma2.5- and 5-mg tablets; 1 mg/mL injection (equivalent to 0.82 mg/mL)Dog: 1.25-5 mg/dog PO q8h\
Cat: 0.1-0.2 mg/kg PO q12h (or 0.625 mg/cat, ¼ of 2.5-mg tablet)Testosterone cypionate esterAndro-Cyp, Andronate, Depo-Testosterone, othersHormone; replacement therapy; most commonly used for testosterone-responsive urinary incontinence in neutered male dogs and cats100 and 200 mg/mL injection1-2 mg/kg IM q2-4 wk (see also *Methyltestosterone*)Testosterone propionate esterTestexHormone; replacement therapy; most commonly used for testosterone-responsive urinary incontinence in neutered male dogs and cats100 mg/mL injection0.5-1 mg/kg IM 2-3 times/wkTetracyclinePanmycinAntibacterial250- and 500-mg capsules; 100 mg/mL suspension15-20 mg/kg PO q8h; or 4.4-11 mg/kg\
IV, IM q8hThenium closylateCanoparAntiparasitic; hookworms500-mg tabletDog: \>4.5 kg, 500 mg PO once and repeat in 2-3 wk; 2.5-4.5 kg, 250 mg q12h for 1 day and repeat in 2-3 wkTheophyllineMany brand name and generic productsBronchodilator; chronic bronchitis and feline asthma100-, 125-, 200-, 250-, and 300-mg tablets; 27 mg/5 mL oral solution or elixir; injection in 5% dextroseDog: 9 mg/kg PO q6-8h\
Cat: 4 mg/kg PO q8-12h (see also *Aminophylline*)Theophylline, sustained-releaseTheo-Dur, Slo-Bid GyrocapsBronchodilator; chronic bronchitis and feline asthma100-, 200-, 300-, and 450-mg tablets (Theo-Dur); 50- to 200-mg capsules (Slo-Bid)Dog: 10 mg/kg PO q12h, if adequate but no side effects increase to 15 mg/kg PO q12h\
Cat: 20 mg/kg PO q24h (at night) for theo-pur and 25 mg/kg PO q24h for slo-bidThiabendazoleOmnizole, Equizole, Tresaderm (topical-otic)Antiparasitic; multiple applications for parasitic infections2 or 4 g/oz (30 mL) suspension or liquidDog: 50 mg/kg q24h for 3 days and repeat in 1 mo;\
Respiratory parasites: 30-70 mg/kg PO q12h\
Cat: *Strongyloides:* 125 mg/kg q24h for 3 daysThiacetarsamide sodiumCaparsolateArsenical; formerly used to treat canine heartworm disease*Not* commercially availableThiamineSee *Vitamin B*~1~Thioguanine (6-TG)GenericAntineoplastic; lymphocytic or granulocytic leukemia40-mg tabletDog: 40 mg/m^2^ PO q24h\
Cat: 25 mg/m^2^ PO q24h for 1-5 daysThiopental sodiumPentothalShort-acting injectable anesthetic; anesthesia induction or restraint for short proceduresVarious size vials from 250 mg to 10 g (mix to desired concentration)Dog: 10-25 mg/kg IV (to effect)\
Cat: 5-10 mg/kg IV (to effect)ThiotepaGenericAntineoplastic; lymphocytic or granulocytic leukemia15-mg injection (usually in solution of 10 mg/mL)0.2-0.5 mg/m^2^/wk, or daily for 5-10 days (IM, intracavitary, or intratumor)Thyroid hormoneSee *Levothyroxine sodium (T*~4~*)* and *Liothyronine (T*~3~*)*Thyrotropin (thyroid-stimulating hormone \[TSH\])ThytroparHormone; used to test for hypothyroidism (primarily in dogs)10-unit vialDog: Collect baseline sample, followed by 0.1 unit/kg IV (maximum dose is 5 U); collect post-TSH sample at 6 hr\
Cat: Collect baseline sample, followed by 2.5 units/cat IM; collect a post-TSH sample 6 hr laterTicarcillinTicar, TicillinAntibacterial6 g/50 mL vial; vials containing 1, 3, 6, 20, and 30 g33-50 mg/kg IV, IM q4-6hTicarcillin + clavulanateTimentinAntibacterial3-g vial for injection33-50 mg/kg IV, IM q4-6hTiletamine + zolazepamTelazol, ZoletilGeneral anesthetic; indicated for restraint and minor procedures of short duration in healthy dogs and catsSterile vial to which 5 mL of sterile water is added; provides the equivalent of 50 mg of tiletamine per milliliter\
*Caution:* Limited shelf life after reconstitutionDosage is based on combined milligrams of each drug. Administer by *deep* intramuscular injection.\
Dog: 6.6-10 mg/kg IM (restraint); 10-13 mg/kg IM deep (minor surgical procedures)\
Do *not* exceed 26.4 mg/kg IM *total dose.*\
Cat: 9.7-11.9 mg/kg IM (restraint), 10.6-12.5 mg/kg IM (minor surgical procedures), 14.3-15.8 mg/kg IM (anesthesia)\
Do *not* exceed 72 mg/kg IM *total dose.*TobramycinNebcinAntibacterial40 mg/mL injection2-4 mg/kg IV, IM, SQ q8h§ TocainideTonocardOral antiarrhythmic; used to manage patients with ventricular arrhythmias400- and 600-mg tabletsDog: 15-20 mg/kg PO q8h\
Cat: Dose not establishedTolazolineTolazineα-Adrenergic blocker; reversal agent for xylazine100 mg/mL in 100-mL multi-dose vials4 mg/kg slowly IV (approx 1 mL/sec)TriamcinoloneVetalog, Trimtabs, Aristocort, genericGlucocorticoid; antiinflammatory (not generally used in the treatment of immune-mediated disease)Veterinary (Vetalog): 0.5- and 1.5-mg tablets\
Human form: 1-, 2-, 4-, 8-, and 16-mg tablets; 10 mg/mL injectionAntiinflammatory: 0.05-0.11 mg/kg two to three times daily, within 2 weeks reduce dose to 0.028-0.055 mg/kg/day (however, manufacturer recommends doses of 0.11-0.22 mg/kg/day)Triamcinolone acetonideVetalogGlucocorticoid; antiinflammatory (not generally used in the treatment of immune-mediated disease)2 and 6 mg/mL suspension injection; 0.5- and 1.5-mg tablets0.1-0.2 mg/kg IM, SQ; repeat in 7-10 days\
Intralesional: 1.2-1.8 mg, or 1 mg for every cm diameter of tumor q2wkTriamtereneDyreniumDiuretic; K-sparing diuretic used as an alternative to spironolactone50- and 100-mg capsules1-2 mg/kg PO q12hTrientine hydrochlorideSyprineOral copper chelating agent; copper-associated hepatopathy; indicated in dogs that cannot tolerate penicillamine250-mg capsulesDog: 10-15 mg/kg PO q12hTrifluoperazineStelazinePhenothiazine; antiemetic10 mg/mL oral solution; also as 1-, 2-, 5-, and 10-mg tablets; 2.0 mg/mL injection0.03 mg/kg IM q12hTriflupromazineVesprinPhenothiazine; antiemetic10 and 20 mg/mL injection0.1-0.3 mg/kg IM, PO q8-12hTriiodothyronineSee *Liothyronine (T*~3~*)*TrilostaneVetorylOral treatment of canine hyperadrenocorticism (pituitary-dependent and adrenal tumor)10-, 30-, 60-mg capsules (available in the United States)3.9 to 9.2 mg/kg/day PO\
Commonly used dose in dogs is 6.1 mg/kg/day PO\
Dose adjustments are made on the basis of routine cortisol testing.Trimeprazine tartrate with prednisoloneTemaril-PPhenothiazine antihistamine + glucocorticoid combination; antitussive and antipruritic; not generally recommended today5 mg trimeprazine + 2-mg prednisolone (combined) tabletDog: See manufacturer\'s recommendations regarding indications and dose.Trimethoprim + sulfonamide (sulfadiazine or sulfamethoxazole)Tribrissen, othersAntibacterial30-, 120-, 240-, 480-, and 960-mg tablets15 mg/kg PO q12h, or 30 mg/kg PO q12-24h\
For *Toxoplasma:* 30 mg/kg PO q12hTSH (thyroid- stimulating hormone)See *Thyrotropin*Tylosin tartrateTylocine, TylanAntibacterial; has antiinflammatory effects in the bowel and is sometimes used to treat inflammatory bowel disease and chronic colitisAvailable as soluble powder with 2.2 g tylosin per teaspoon (tablets available for dogs in Canada)Dog and cat: 7-15 mg/kg PO q12-24h\
Dog (for colitis): 11 mg/kg q8h with foodUrsodiol (ursodeoxycholic acid)ActigallBile acid; adjunctive therapy in patients with chronic liver disease300-mg capsule10-15 mg/kg PO q24hValproic acidDepakene (valproic acid), Depakote (divalproex)Anticonvulsant; uncommonly used alternative to conventional anticonvulsant therapyDepakote: 125-, 250-, and 500-mg tablets\
Depakene: 250-mg capsule; 50 mg/mL syrupDog: 60-200 mg/kg PO q8h; or divalproex 25-105 mg/kg/day PO when administered with phenobarbital\
Cat: *Do not use*VancomycinVancocin; VancoledAntibacterialVials for injection (0.5 to 10 g)Dog: 15 mg/kg q6-8h IV by CRI\
Cat: 12-15 mg/kg q8h IV by CRIVasopressin (ADH)PitressinHormone; diagnostic test agent to distinguish central diabetes insipidus from nephrogenic diabetes insipidus (not routinely recommended); see also *Desmopressin acetate* for treatment of diabetes insipidus.20 (pressor) units/mL in 0.5-, 1.0-, and 10-mL vials (aqueous only) and 1-mL ampulesFor diagnostic purposes:\
Dog: Test protocol: administer 2 mcg IM to dogs \< 15 kg body weight; administer 4 mcg IM to dogs \> 15 kg\
*Note:* Diabetes insipidus test protocol entails patient preparation in advance of administration of vasopressin.§ VerapamilCalan, IsoptinCalcium channel blocker; supraventricular tachycardia and hypertension40-, 80-, and 120-mg tablets; 2.5 mg/mL injectionDog: 0.05 mg/kg, IV slowly (can repeat every 5 min) to a maximum cumulative dose of 0.15-0.2 mg/kg\
For hypertension: 1-5 mg/kg PO q8h\
Cat: 0.025 mg/kg IV slowly (can repeat every 5 minutes) to a maximum cumulative dose of 0.15-0.2 mg/kgVinblastineVelbanVinca alkaloid, antineoplastic1 mg/mL injection2 mg/m^2^ IV (slow infusion) q7-14 days§ VincristineOncovin, Vincasar, genericVinca alkaloid, antineoplastic; also for the treatment of thrombocytopenia1 mg/mL injectionAntitumor: 0.5-0.75 mg/m^2^ IV q7-14 days (q7days in cats, depending on protocol); for thrombocytopenia: 0.02 mg/kg IV, once weekly (alternatively, 0.5-0.7 mg/m^2^ as an infusion over 4-6 hr) each weekViokaseSee *Pancreatic Enzymes*Vitamin A (retinoids)Aquasol AVitamin; nutritional supplementationOral solution: 5000 units per 0.1 mL and 10,000-, 25,000-, and 50,000-unit tablets625-800 units/kg PO q24hVitamin B~1~ThiamineVitamin; nutritional supplementation250 mcg/5 mL elixir; tablets of various sizes from 5 mg to 500 mg; 100 and 500 mg/mL injectionDog: 10-100 mg/dog/day PO\
Cat: 5-30 mg/cat/day PO (up to maximum dose of 50 mg/cat/day)Vitamin B~2~RiboflavinVitamin; nutritional supplementationTablets of various sizes in increments of 10 to 250 mg; 100 mcg/mL injectionDog: 10-20 mg/day PO\
Cat: 5-10 mg/day POVitamin B~12~CyanocobalaminVitamin; nutritional supplementation100 mcg/mL injectionDog: 100-200 mcg/day PO\
Cat: 50-100 mcg/day POVitamin CAscorbic acidTablets of various sizes and injection100-500 mg/dayVitamin D analogueDihydrotachysterol (DHT), HytakerolVitamin; management of hypocalcemia associated with hypoparathyroidism or parathyroid gland surgery0.125-mg tablet; 0.5 mg/mL oral liquid0.01 mg/kg/day PO\
Acute treatment: 0.02 mg/kg initially; then 0.01-0.03 mg/kg PO q24-48h thereafterVitamin D~2~Ergocalciferol, Calciferol, DrisdolVitamin; management of hypocalcemia associated with hypoparathyroidism or parathyroid gland surgery400-unit tablet (OTC); 50,000-unit tablet (1.25 mg); 500,000 units/mL (12.5 mg/mL) injection4000 to 6000 units/kg/day PO (initial); 1000 to 2000 units/kg/day PO (maintenance)Vitamin D~3~1-25, dihydroxyvitamin D~3~Vitamin, also considered a hormone; management of hypocalcemia associated with hypoparathyroidism or parathyroid gland surgery; also used to supplement hypocalcemia of chronic renal failureSee *Vitamin D analogue*Hypocalcemia:\
0.030-0.06 mcg/kg PO once daily\
Chronic renal failure: 0.025 mcg/kg PO once dailyVitamin E (may be combined with selenium)alpha-tocopherol, Aquasol E, genericVitamin; nutritional supplementation and adjunctive therapy in patients with chronic liver disease; may be combined with selenium as adjunctive therapy for immune-mediated skin disease in dogs; efficacy in management of arthritic dogs is questionableWide variety of capsules, tablets, oral solution available (e.g., 1000 units per capsule)See manufacturer\'s recommendations for treatment indications and dose§ Vitamin K~1~Phytonadione, phytomenadione, Aqua-MEPHYTON (injection), Mephyton (tablets), Veta-K1 (capsules)Antidote; anticoagulant rodenticide toxicosis and in any disorder affecting formation of vitamin K--dependent coagulation factors2 and 10 mg/mL injection; 5-mg tablet (Mephyton); 25-mg capsule (Veta-K1)Rodenticide toxicosis: 2.5-5.0 mg/kg/day PO (preferred) for up to 6 weeks depending on the agent ingested. Acute intoxication: 5 mg/kg SQ in multiple locations with 25-gauge needleWarfarinCoumadin and genericAnticoagulant; adjunctive treatment for and prevention of thromboemboli1-, 2-, 2.5-, 4-, 5-, 7.5- and 10-mg tabletsDog: 0.22 mg/kg PO q12h to prolong PT by 1.25 to 1.5 times normal\
Pulmonary thromboemboli: 0.2 mg/kg PO daily to prolong PT by 1.5 to 2.5 times normal\
Cat:\
Chronic treatment: 0.1-0.2 mg/kg PO once daily to prolong PT by 2 to 2.5 times normal\
Aortic embolus: 0.06-0.1 mg/kg PO once dailyXylazineRompun and genericα~2~-Adrenergic agonist; sedative and analgesic (sometimes used as an emetic in cats)20 and 100 mg/mL injectionDog and cat: 1.1 mg/kg IV; or 1.1 to 2.2 mg/kg IM or SQ\
Cat (to induce emesis): 0.4-0.5 mg/kg IVYohimbineYobineα~2~-Adrenergic antagonist; reverses xylazine (and possibly amitraz)2 mg/mL injection in 20-mL vials0.11 mg/kg IV slowlyZidovudine (AZT)RetrovirAntiretroviral agent; adjunctive treatment of FeLV- and FIV-positive cats300-mg tablets; 100-mg capsules; 10 mg/mL syrup 10 mg/mL injectionCat: 5-15 mg/kg PO q12h; or 5 mg/kg PO q8h for 5 wk and then rest for 4 wk\
*Caution:* Significant bone marrow suppression (usually reversible with cessation of therapy) is expected; monitor CBC during therapy.ZolazepamSee *Tiletamine*+ *zolazepam*[^22][^23][^24]

Presented in alphabetical order.

[^1]: All species listed except rabbits are seasonally polyestrous.

[^2]: Better source of vitamin C than lettuce.

[^3]: *AST,* Aspartate aminotransferase; *BUN,* blood urea nitrogen; *RBCs,* red blood cells; *WBCs,* white blood cells.

[^4]: These are values found in healthy-appearing animals and can be used as guides but should not be interpreted as physiologic norms for the species listed.

[^5]: *RBCs,* Red blood cells; *WBCs,* white blood cells.

[^6]: Values are for both sexes.

[^7]: *AST,* Aspartate aminotransferase; *BUN,* blood urea nitrogen.

[^8]: Values for both sexes.

[^9]: *bpm*, Beats per minute; *s*, seconds; *mV*, millivolts.

[^10]: Ferrets in right lateral recumbency; sedation with ketamine and xylazine.

[^11]: 1 cc (or cubic centimeter) = 1 cm^3^ = 1 mL.

[^12]: *NR,* Not generally recommended.

[^13]: *NR,* Not generally recommended.

[^14]: Because of the high susceptibility of kittens to infection, current guidelines state that feline leukemia virus (FeLV) vaccination is "highly recommended" for all kittens and cats. Consequently, FeLV vaccination becomes noncore thereafter.

[^15]: *MLV*, Modified live virus.

[^16]: *MLV,* Modified live virus.

[^17]: *Note:* The Feline Infectious Peritonitis (FIP) vaccine is deemed "not generally recommended" by the AAFP Vaccine Advisory Panel.

[^18]: *MLV,* Modified live virus.

[^19]: Other noncore vaccines are seldom administered and should be considered only after assessing and defining a clear risk of exposure. All other noncore vaccines are recommended for annual administration as long as the risk of exposure persists.

[^20]: The material in this report originated at the National Center for Infectious Diseases (Anne Schuchat, MD, Acting Director) and the Division of Viral and Rickettsial Diseases (James W. LeDuc, PhD, Director).

[^21]: The NASPHV Committee: Suzanne R. Jenkins, VMD, MPH, Co-Chair; Mira J. Leslie, DVM, MPH, Co-Chair; Michael Auslander, DVM, MSPH; Lisa Conti, DVM, MPH; Paul Ettestad, DVM, MS; Faye E. Sorhage, VMD, MPH; and Ben Sun, DVM, MPVM. Consultants to the Committee: Donna M. Gatewood, DVM, MS, Center for Veterinary Biologics, U.S. Department of Agriculture (USDA); Ellen Mangione, MD, MPH, Council of State and Territorial Epidemiologists (CSTE); Lorraine Moule, National Animal Control Association (NACA); Greg Pruitt, Animal Health Institute; Charles E. Rupprecht, VMD, MS, PhD, CDC; John Schiltz, DVM, American Veterinary Medical Association (AVMA); Charles V. Trimarchi, MS, New York State Health Department; and Dennis Slate, PhD, Wildlife Services, USDA. This compendium has been endorsed by AVMA, CDC, CSTE, and NACA. Corresponding author: Mira J. Leslie, DVM, MPH, Washington Department of Health, Communicable Disease Epidemiology, 1610 NE 150th Street, MS K17-9, Shoreline, WA 98155-9701.

[^22]: *ACE,* Angiotensin-converting enzyme; *ACTH,* adrenocorticotropic hormone; *ADH,* antidiuretic hormone; *CBC,* complete blood count; *CMI,* cell-mediated immunity; *CNS,* central nervous system; *CRI,* constant-rate infusion; *CSF,* cerebrospinal fluid; *D5W,* dextrose 5% in water; *DI,* diabetes insipidus; *DIC,* disseminated intravascular coagulation; *FeLV,* feline leukemia virus; *FIV,* feline immunodeficiency virus; *GABA,* γ-aminobutyric acid; *GI,* gastrointestinal; *GnRH,* gonadotropin-releasing hormone; *H*~2~*,* histamine~2~; *IM,* intramuscularly; *IMHA,* immune-mediated hemolytic anemia; *IP,* intraperitoneally; *IV,* intravenously; *LH,* luteinizing hormone; *LHRH,* luteinizing-hormone--releasing hormone; *MOA,* monoamine oxidase; *NSAID*, nonsteroidal antiinflammatory drug; *OTC,* over the counter (prescription not required); *PO,* orally; *PT,* prothrombin time; *SQ,* subcutaneously; *SSRI,* selective serotonin reuptake inhibitor; *USP,* United States Pharmacopeia.

[^23]: Listings preceded by § are for rapid reference and denote drug or dose used in the emergency or critical care setting.

[^24]: Doses listed in this table are based on best available evidence at the time of table preparation; although considerable effort has been made to verify all doses listed, it is prudent to verify treatment protocols and drug dosages whenever using a product for the first time. Adverse effects may be possible from virtually any of the drugs listed in this table. High-risk warnings and precautionary statements are listed. Veterinarians using this table are encouraged to check current literature, product label, and manufacturer\'s disclosure for information regarding reported changes in efficacy or safety as well as any new treatment contraindications not identified at the time of preparation of these tables. When dose listed does *not* stipulate dog or cat, drug may be administered to both dogs and cats at the dose listed.
